1
|
Coolen T, Mihai Dumitrescu A, Wens V, Bourguignon M, Rovai A, Sadeghi N, Urbain C, Goldman S, De Tiège X. Spectrotemporal cortical dynamics and semantic control during sentence completion. Clin Neurophysiol 2024; 163:90-101. [PMID: 38714152 DOI: 10.1016/j.clinph.2024.04.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Revised: 03/27/2024] [Accepted: 04/14/2024] [Indexed: 05/09/2024]
Abstract
OBJECTIVE To investigate cortical oscillations during a sentence completion task (SC) using magnetoencephalography (MEG), focusing on the semantic control network (SCN), its leftward asymmetry, and the effects of semantic control load. METHODS Twenty right-handed adults underwent MEG while performing SC, consisting of low cloze (LC: multiple responses) and high cloze (HC: single response) stimuli. Spectrotemporal power modulations as event-related synchronizations (ERS) and desynchronizations (ERD) were analyzed: first, at the whole-brain level; second, in key SCN regions, posterior middle/inferior temporal gyri (pMTG/ITG) and inferior frontal gyri (IFG), under different semantic control loads. RESULTS Three cortical response patterns emerged: early (0-200 ms) theta-band occipital ERS; intermediate (200-700 ms) semantic network alpha/beta-band ERD; late (700-3000 ms) dorsal language stream alpha/beta/gamma-band ERD. Under high semantic control load (LC), pMTG/ITG showed prolonged left-sided engagement (ERD) and right-sided inhibition (ERS). Left IFG exhibited heightened late (2500-2550 ms) beta-band ERD with increased semantic control load (LC vs. HC). CONCLUSIONS SC involves distinct cortical responses and depends on the left IFG and asymmetric engagement of the pMTG/ITG for semantic control. SIGNIFICANCE Future use of SC in neuromagnetic preoperative language mapping and for understanding the pathophysiology of language disorders in neurological conditions.
Collapse
Affiliation(s)
- Tim Coolen
- Université Libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles (LN(2)T), Brussels, Belgium; Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Radiology, Brussels, Belgium.
| | - Alexandru Mihai Dumitrescu
- Université Libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles (LN(2)T), Brussels, Belgium
| | - Vincent Wens
- Université Libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles (LN(2)T), Brussels, Belgium
| | - Mathieu Bourguignon
- Université Libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles (LN(2)T), Brussels, Belgium; Université Libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratory of Neurophysiology and Movement Biomechanics, Brussels, Belgium
| | - Antonin Rovai
- Université Libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles (LN(2)T), Brussels, Belgium
| | - Niloufar Sadeghi
- Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Radiology, Brussels, Belgium
| | - Charline Urbain
- Université Libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles (LN(2)T), Brussels, Belgium; Université Libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Centre for Research in Cognition and Neurosciences (CRCN), Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Brussels, Belgium
| | - Serge Goldman
- Université Libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles (LN(2)T), Brussels, Belgium
| | - Xavier De Tiège
- Université Libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles (LN(2)T), Brussels, Belgium
| |
Collapse
|
2
|
Lancaster JJ, Grijalva A, Fink J, Ref J, Daugherty S, Whitman S, Fox K, Gorman G, Lancaster LD, Avery R, Acharya T, McArthur A, Strom J, Pierce MK, Moukabary T, Borgstrom M, Benson D, Mangiola M, Pandey AC, Zile MR, Bradshaw A, Koevary JW, Goldman S. Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine hearts. Commun Biol 2023; 6:1203. [PMID: 38007534 PMCID: PMC10676365 DOI: 10.1038/s42003-023-05564-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Accepted: 11/09/2023] [Indexed: 11/27/2023] Open
Abstract
There are nearly 65 million people with chronic heart failure (CHF) globally, with no treatment directed at the pathologic cause of the disease, the loss of functioning cardiomyocytes. We have an allogeneic cardiac patch comprised of cardiomyocytes and human fibroblasts on a bioresorbable matrix. This patch increases blood flow to the damaged heart and improves left ventricular (LV) function in an immune competent rat model of ischemic CHF. After 6 months of treatment in an immune competent Yucatan mini swine ischemic CHF model, this patch restores LV contractility without constrictive physiology, partially reversing maladaptive LV and right ventricular remodeling, increases exercise tolerance, without inducing any cardiac arrhythmias or a change in myocardial oxygen consumption. Digital spatial profiling in mice with patch placement 3 weeks after a myocardial infarction shows that the patch induces a CD45pos immune cell response that results in an infiltration of dendritic cells and macrophages with high expression of macrophages polarization to the anti-inflammatory reparative M2 phenotype. Leveraging the host native immune system allows for the potential use of immunomodulatory therapies for treatment of chronic inflammatory diseases not limited to ischemic CHF.
Collapse
Affiliation(s)
- J J Lancaster
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - A Grijalva
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - J Fink
- Division of Blood & Marrow Transplant & Cellular Therapy, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, 55455, USA
| | - J Ref
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - S Daugherty
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - S Whitman
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - K Fox
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
- Division of Cardiothoracic Surgery, Department of Surgery, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - G Gorman
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - L D Lancaster
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - R Avery
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - T Acharya
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - A McArthur
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - J Strom
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - M K Pierce
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - T Moukabary
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - M Borgstrom
- Research & Discovery Tech, Research Computing Specialist, Principal, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - D Benson
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
| | - M Mangiola
- Department of Pathology, NYU Grossman School of Medicine, New York City, NY, 11016, USA
| | - A C Pandey
- Section of Cardiology, Tulane University Heart and Vascular Institute, John W. Deming Department of Medicine, Section of Cardiology, Department of Medicine, Southeast Louisiana Veterans Healthcare System, Tulane University School of Medicine, New Orleans, LA, 70122, USA
| | - M R Zile
- Ralph H. Johnson VA Medical Center, Division of Cardiology, Medical University of South Carolina, Thurmond/Gazes Building, 30 Courtenay Drive, Charleston, SC, 29425, USA
| | - A Bradshaw
- Ralph H. Johnson VA Medical Center, Division of Cardiology, Medical University of South Carolina, Thurmond/Gazes Building, 30 Courtenay Drive, Charleston, SC, 29425, USA
| | - J W Koevary
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA
- Biomedical Engineering, College of Engineering, University of Arizona, 1127 E. James E. Rogers Way, Tucson, AZ, 85721, USA
| | - S Goldman
- Sarver Heart Center, Department of Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA.
| |
Collapse
|
3
|
Lavis P, Pingitore J, Doumont G, Garabet A, Van Simaeys G, Lacroix S, Passon N, Van Heymbeek C, De Maeseneire C, Allard J, Collin A, Huaux F, Decaestecker C, Salmon I, Goldman S, Cardozo AK, Bondue B. Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis. Respir Res 2023; 24:254. [PMID: 37880678 PMCID: PMC10601150 DOI: 10.1186/s12931-023-02556-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2023] [Accepted: 10/05/2023] [Indexed: 10/27/2023] Open
Abstract
BACKGROUND Fibroblast activation protein-α (FAPα) is a marker of activated fibroblasts that can be selectively targeted by an inhibitor (FAPI) and visualised by PET/CT imaging. We evaluated whether the measurement of FAPα in bronchoalveolar lavage fluids (BALF) and the uptake of FAPI by PET/CT could be used as biomarkers of fibrogenesis. METHODS The dynamics of lung uptake of 18F-labeled FAPI ([18F]FAPI-74) was assessed in the bleomycin mouse model at various time points and using different concentrations of bleomycin by PET/CT. FAPα was measured in BALFs from these bleomycin-treated and control mice. FAPα levels were also assessed in BALFs from controls and patients with idiopathic pulmonary fibrosis (IPF). RESULTS Bleomycin-treated mice presented a significantly higher uptake of [18F]FAPI-74 during lung fibrinogenesis (days 10 and 16 after instillation) compared to control mice. No significant difference was observed at initial inflammatory phase (3 days) and when fibrosis was already established (28 days). [18F]FAPI-74 tracer was unable to show a dose-response to bleomycin treatment. On the other hand, BALF FAPα levels were steeply higher in bleomycin-treated mice at day 10 and a significant dose-response effect was observed. Moreover, FAPα levels were strongly correlated with lung fibrosis as measured by the modified Aschroft histological analysis, hydroxyproline and the percentage of weight loss. Importantly, higher levels of FAPα were observed in IPF patients where the disease was progressing as compared to stable patients and controls. Moreover, patients with FAPα BALF levels higher than 192.5 pg/mL presented a higher risk of progression, transplantation or death compared to patients with lower levels. CONCLUSIONS Our preclinical data highlight a specific increase of [18F]FAPI-74 lung uptake during the fibrotic phase of the bleomycin murine model. The measurement of FAPα in BALF appears to be a promising marker of the fibrotic activity in preclinical models of lung fibrosis and in IPF patients. Further studies are required to confirm the role of FAPα in BALF as biomarker of IPF activity and assess the relationship between FAPα levels in BALF and [18F]FAPI-74 uptake on PET/CT in patients with fibrotic lung disease.
Collapse
Affiliation(s)
- Philomène Lavis
- Department of Pathology, Hôpital universitaire de Bruxelles (Hôpital Erasme), Université libre de Bruxelles, Brussels, Belgium
- I.R.I.B.H.M, Université libre de Bruxelles, Brussels, Belgium
| | - Julien Pingitore
- Department of Pneumology, Hôpital universitaire de Bruxelles (Hôpital Erasme), Université libre de Bruxelles, Brussels, Belgium
| | - Gilles Doumont
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
| | - Ani Garabet
- Inflammation and Cell Death Signalling group, Experimental Gastroenterology Laboratory and Endotools, Université libre de Bruxelles, Brussels, Belgium
| | - Gaetan Van Simaeys
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
- Department of Nuclear Medicine, Hôpital universitaire de Bruxelles (Hôpital Erasme), Université libre de Bruxelles, Brussels, Belgium
| | - Simon Lacroix
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
- Department of Nuclear Medicine, Hôpital universitaire de Bruxelles (Hôpital Erasme), Université libre de Bruxelles, Brussels, Belgium
| | - Nicolas Passon
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
| | - Christophe Van Heymbeek
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
| | - Coraline De Maeseneire
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
| | - Justine Allard
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
| | - Amandine Collin
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
| | - François Huaux
- Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium
| | - Christine Decaestecker
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
- Laboratory of Image Synthesis and Analysis, Université libre de Bruxelles, Brussels, Belgium
| | - Isabelle Salmon
- Department of Pathology, Hôpital universitaire de Bruxelles (Hôpital Erasme), Université libre de Bruxelles, Brussels, Belgium
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
- Centre Universitaire inter Régional d'expertise en Anatomie Pathologique Hospitalière, Jumet, Belgium
| | - Serge Goldman
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Brussels, Belgium
- Department of Nuclear Medicine, Hôpital universitaire de Bruxelles (Hôpital Erasme), Université libre de Bruxelles, Brussels, Belgium
| | - Alessandra Kupper Cardozo
- Inflammation and Cell Death Signalling group, Experimental Gastroenterology Laboratory and Endotools, Université libre de Bruxelles, Brussels, Belgium
| | - Benjamin Bondue
- I.R.I.B.H.M, Université libre de Bruxelles, Brussels, Belgium.
- Department of Pneumology, Hôpital universitaire de Bruxelles (Hôpital Erasme), Université libre de Bruxelles, Brussels, Belgium.
| |
Collapse
|
4
|
Bruffaerts R, Pongos A, Shain C, Lipkin B, Siegelman M, Wens V, Sjøgård M, Pantazis D, Blank I, Goldman S, De Tiège X, Fedorenko E. Functional identification of language-responsive channels in individual participants in MEG investigations. bioRxiv 2023:2023.03.23.533424. [PMID: 36993378 PMCID: PMC10055362 DOI: 10.1101/2023.03.23.533424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/19/2023]
Abstract
Making meaningful inferences about the functional architecture of the language system requires the ability to refer to the same neural units across individuals and studies. Traditional brain imaging approaches align and average brains together in a common space. However, lateral frontal and temporal cortex, where the language system resides, is characterized by high structural and functional inter-individual variability. This variability reduces the sensitivity and functional resolution of group-averaging analyses. This problem is compounded by the fact that language areas often lay in close proximity to regions of other large-scale networks with different functional profiles. A solution inspired by other fields of cognitive neuroscience (e.g., vision) is to identify language areas functionally in each individual brain using a 'localizer' task (e.g., a language comprehension task). This approach has proven productive in fMRI, yielding a number of discoveries about the language system, and has been successfully extended to intracranial recording investigations. Here, we apply this approach to MEG. Across two experiments (one in Dutch speakers, n=19; one in English speakers, n=23), we examined neural responses to the processing of sentences and a control condition (nonword sequences). We demonstrated that the neural response to language is spatially consistent at the individual level. The language-responsive sensors of interest were, as expected, less responsive to the nonwords condition. Clear inter-individual differences were present in the topography of the neural response to language, leading to greater sensitivity when the data were analyzed at the individual level compared to the group level. Thus, as in fMRI, functional localization yields benefits in MEG and thus opens the door to probing fine-grained distinctions in space and time in future MEG investigations of language processing.
Collapse
Affiliation(s)
- Rose Bruffaerts
- Computational Neurology, Experimental Neurobiology Unit (ENU), Department of Biomedical Sciences, University of Antwerp, Belgium; Department of Neurosciences, KU Leuven, Belgium
- Brain and Cognitive Sciences Department, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Alvince Pongos
- Brain and Cognitive Sciences Department, Massachusetts Institute of Technology, Cambridge, MA, USA
- Department of Bioengineering, UC Berkeley-UCSF, San Francisco, CA, USA
| | - Cory Shain
- Brain and Cognitive Sciences Department, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Benjamin Lipkin
- Brain and Cognitive Sciences Department, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Matthew Siegelman
- Brain and Cognitive Sciences Department, Massachusetts Institute of Technology, Cambridge, MA, USA
- Department of Psychology, Columbia University, New York, NY, USA
| | - Vincent Wens
- Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles, Brussels, Belgium
| | - Martin Sjøgård
- Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles, Brussels, Belgium
| | - Dimitrios Pantazis
- McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Idan Blank
- Brain and Cognitive Sciences Department, Massachusetts Institute of Technology, Cambridge, MA, USA
- Department of Psychology, University of California Los Angeles, CA, USA
| | - Serge Goldman
- Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles, Brussels, Belgium
| | - Xavier De Tiège
- Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles, Brussels, Belgium
| | - Evelina Fedorenko
- Brain and Cognitive Sciences Department, Massachusetts Institute of Technology, Cambridge, MA, USA
- McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA
| |
Collapse
|
5
|
Henrard S, Trotta N, Rovai A, Coolen T, Slama H, Bertels J, Puttaert D, Goffard JC, Van Vooren JP, Goldman S, De Tiège X. Impact of Human Immunodeficiency Virus and Recreational Drugs on Cognitive Functions. Clin Infect Dis 2023; 76:1022-1029. [PMID: 36358021 DOI: 10.1093/cid/ciac870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 10/27/2022] [Accepted: 11/01/2022] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND This prospective study characterizes the structural and metabolic cerebral correlates of cognitive impairments found in a preclinical setting that considers the lifestyle of young European men exposed to human immunodeficiency virus (HIV), including recreational drugs. METHODS Simultaneous structural brain magnetic resonance imaging (MRI) and positron emission tomography using [18F]-fluorodeoxyglucose (FDG-PET) were acquired on a hybrid PET-MRI system in 23 asymptomatic young men having sex with men with HIV (HIVMSM; mean age, 33.6 years [range, 23-60 years]; normal CD4+ cell count, undetectable viral load). Neuroimaging data were compared with that of 26 young seronegative men under HIV preexposure prophylaxis (PrEPMSM), highly well matched for age and lifestyle, and to 23 matched young seronegative men (controls). A comprehensive neuropsychological assessment was also administered to the HIVMSM and PrEPMSM participants. RESULTS HIVMSM had lower performances in executive, attentional, and working memory functions compared to PrEPMSM. No structural or metabolic differences were found between those 2 groups. Compared to controls, HIVMSM and PrEPMSM exhibited a common hypometabolism in the prefrontal cortex that correlated with the level of recreational drug use. No structural brain abnormality was found. CONCLUSIONS Abnormalities of brain metabolism in our population of young HIVMSM mainly relate to recreational drug use rather than HIV per se. A complex interplay between recreational drugs and HIV might nevertheless be involved in the cognitive impairments observed in this population.
Collapse
Affiliation(s)
- Sophie Henrard
- Department of Internal Medicine and Immunodeficiency, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B.), Clinique Universitaire de Bruxelles (CUB) Hôpital Erasme, Brussels 1070, Belgium
- Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles, ULB Neuroscience Institute, ULB, Brussels 1070, Belgium
| | - Nicola Trotta
- Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles, ULB Neuroscience Institute, ULB, Brussels 1070, Belgium
- Departments of Nuclear Medicine, Brussels 1070, Belgium
- Translational Neuroimaging, Brussels 1070, Belgium
| | - Antonin Rovai
- Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles, ULB Neuroscience Institute, ULB, Brussels 1070, Belgium
- Translational Neuroimaging, Brussels 1070, Belgium
| | - Tim Coolen
- Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles, ULB Neuroscience Institute, ULB, Brussels 1070, Belgium
- Radiology, Brussels 1070, Belgium
| | - Hichem Slama
- Clinical Neuropsychology, ULB, H.U.B., CUB Hôpital Erasme, Brussels 1070, Belgium
| | - Julie Bertels
- Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles, ULB Neuroscience Institute, ULB, Brussels 1070, Belgium
- UlBabyLab-Consciousness, Cognition and Computation Group, Center for Research in Cognition and Neurosciences, ULB Neuroscience Institute, ULB, Brussels, Belgium
| | - Delphine Puttaert
- Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles, ULB Neuroscience Institute, ULB, Brussels 1070, Belgium
| | - Jean-Christophe Goffard
- Department of Internal Medicine and Immunodeficiency, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B.), Clinique Universitaire de Bruxelles (CUB) Hôpital Erasme, Brussels 1070, Belgium
| | - Jean-Paul Van Vooren
- Department of Internal Medicine and Immunodeficiency, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B.), Clinique Universitaire de Bruxelles (CUB) Hôpital Erasme, Brussels 1070, Belgium
| | - Serge Goldman
- Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles, ULB Neuroscience Institute, ULB, Brussels 1070, Belgium
- Departments of Nuclear Medicine, Brussels 1070, Belgium
| | - Xavier De Tiège
- Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles, ULB Neuroscience Institute, ULB, Brussels 1070, Belgium
- Translational Neuroimaging, Brussels 1070, Belgium
| |
Collapse
|
6
|
Feys O, Goldman S, Lolli V, Depondt C, Legros B, Gaspard N, Schuind S, De Tiège X, Rikir E. Diagnostic and therapeutic approaches in refractory insular epilepsy. Epilepsia 2023. [PMID: 36869701 DOI: 10.1111/epi.17571] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2023] [Revised: 02/17/2023] [Accepted: 03/02/2023] [Indexed: 03/05/2023]
Abstract
Due to heterogenous seizure semiology and poor contribution of scalp EEG signals, insular epilepsy requires the use of appropriate diagnostic tools for its diagnosis and characterization. The deep location of the insula also presents surgical challenges. The aim of this paper is to review current diagnostic and therapeutic tools and their contribution to the management of insular epilepsy. Magnetic resonance imaging, isotopic imaging, neurophysiological imaging, and genetic testing should be used and interpretated with caution. Isotopic imaging and scalp electroencephalography have demonstrated a lower value in epilepsy from insular compared to temporal origin, which increases the interest of functional magnetic resonance imaging and magnetoencephalography. Intracranial recording with stereo-electroencephalography is often required. The insular cortex, being highly connected and deeply located under highly functional areas, is difficult to reach, and its ablative surgery raises functional issues. Tailored resection based on stereo-electroencephalography or alternative curative treatments, such as radiofrequency thermocoagulation, laser interstitial thermal therapy or stereotactic radiosurgery, have produced encouraging results. The management of insular epilepsy has benefited from major advances in the last years. Perspectives for diagnostic and therapeutic procedures will contribute to better management of this complex form of epilepsy.
Collapse
Affiliation(s)
- Odile Feys
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Neurology, Brussels, Belgium.,Université libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles, (LN2T), Brussels, Belgium
| | - Serge Goldman
- Université libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles, (LN2T), Brussels, Belgium.,Université libre de Bruxelles (ULB), HUB Hôpital Erasme, Department of Nuclear Medicine, Brussels, Belgium
| | - Valentina Lolli
- Université libre de Bruxelles (ULB), HUB Hôpital Erasme, Department of Radiology, Brussels, Belgium
| | - Chantal Depondt
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Neurology, Brussels, Belgium
| | - Benjamin Legros
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Neurology, Brussels, Belgium
| | - Nicolas Gaspard
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Neurology, Brussels, Belgium.,Yale University School of Medicine, Department of Neurology, New Haven, CT, USA
| | - Sophie Schuind
- Université libre de Bruxelles (ULB), HUB Hôpital Erasme, Department of Neurosurgery, Brussels, Belgium
| | - Xavier De Tiège
- Université libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroanatomie et Neuroimagerie Translationnelles, (LN2T), Brussels, Belgium.,Université libre de Bruxelles (ULB), HUB Hôpital Erasme, Department of Translational Neuroimaging, Brussels, Belgium
| | - Estelle Rikir
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Neurology, Brussels, Belgium
| |
Collapse
|
7
|
Feys O, Corvilain P, Van Hecke A, Sculier C, Rikir E, Legros B, Gaspard N, Leurquin-Sterk G, Holmes N, Brookes M, Goldman S, Wens V, De Tiège X. Recording of Ictal Epileptic Activity Using on-Scalp Magnetoencephalography. Ann Neurol 2023; 93:419-421. [PMID: 36480016 DOI: 10.1002/ana.26562] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2022] [Revised: 11/23/2022] [Accepted: 11/25/2022] [Indexed: 12/13/2022]
Affiliation(s)
- Odile Feys
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Neurology, Brussels, Belgium.,Université libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroimagerie et Neuroanatomie translationnelles (LN2T), Brussels, Belgium
| | - Pierre Corvilain
- Université libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroimagerie et Neuroanatomie translationnelles (LN2T), Brussels, Belgium
| | - Audrey Van Hecke
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Department of Pediatric Neurology, Brussels, Belgium
| | - Claudine Sculier
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Pediatric Neurology, Brussels, Belgium
| | - Estelle Rikir
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Neurology, Brussels, Belgium
| | - Benjamin Legros
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Neurology, Brussels, Belgium
| | - Nicolas Gaspard
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Neurology, Brussels, Belgium
| | - Gil Leurquin-Sterk
- Université libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroimagerie et Neuroanatomie translationnelles (LN2T), Brussels, Belgium.,University of Nottingham, School of Physics and Astronomy, Sir Peter Mansfield Imaging Centre, Nottingham, United Kingdom
| | - Niall Holmes
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Nuclear Medicine, Brussels, Belgium
| | - Matthew Brookes
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Nuclear Medicine, Brussels, Belgium
| | - Serge Goldman
- Université libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroimagerie et Neuroanatomie translationnelles (LN2T), Brussels, Belgium.,University of Nottingham, School of Physics and Astronomy, Sir Peter Mansfield Imaging Centre, Nottingham, United Kingdom
| | - Vincent Wens
- Université libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroimagerie et Neuroanatomie translationnelles (LN2T), Brussels, Belgium.,Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Translational Neuroimaging, Brussels, Belgium
| | - Xavier De Tiège
- Université libre de Bruxelles (ULB), ULB Neuroscience Institute (UNI), Laboratoire de Neuroimagerie et Neuroanatomie translationnelles (LN2T), Brussels, Belgium.,Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Translational Neuroimaging, Brussels, Belgium
| |
Collapse
|
8
|
Vierasu I, Van Simaeys G, Trotta N, Lacroix S, Bormans G, Albisinni S, Quackels T, Roumeguère T, Goldman S. 18F-JK-PSMA-7 PET/CT for staging intermediate- or high-risk prostate cancer patients before radical prostatectomy: a pilot study. Eur J Hybrid Imaging 2023; 7:2. [PMID: 36683076 PMCID: PMC9868215 DOI: 10.1186/s41824-022-00161-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Accepted: 12/28/2022] [Indexed: 01/24/2023] Open
Abstract
BACKGROUND Positron emission tomography/computed tomography (PET/CT) using radiotracers that bind to the prostate-specific membrane antigen (PSMA) is mainly used in biochemical recurring prostate cancer. The aim of our study was to assess the usefulness of 18F-JK-PSMA-7 PET/CT for local and nodal staging in patients with intermediate- and high-risk prostate cancer (PCa) prior to radical prostatectomy, as compared to conventional imaging techniques. METHODS We enrolled a total of 10 patients with intermediate- and high-risk PCa diagnosed by multiparametric-MRI followed by systematic and targeted biopsies, eligible for radical prostatectomy with extended lymph node dissection. Clinical team was blind to the results of the pre-surgery 18F-JK-PSMA-7 PET/CT at times of clinical decision and surgery. One month post-surgery, 18F-JK-PSMA-7 PET/CT was repeated and the results of both scans were unblinded. A third 18F-JK-PSMA-7 PET/CT could be acquired at a later time point depending on PSA progression. RESULTS All pre-surgery 18F-JK-PSMA-7 PET/CT was positive in the prostatic region, while MRI was negative in the prostate in one patient. We also detected positive pelvic lymph nodes in two patients (one high-risk, one intermediate-risk PCa) on pre-surgery and post-surgery 18F-JK-PSMA-7 PET/CT. No positive pelvic lymph nodes were reported on pre-surgical CT and MRI. 18F-JK-PSMA-7 PET/CT detected bladder involvement in one patient and seminal vesicles involvement in two patients; this malignant extension was undetected by the conventional imaging techniques. SUVmax in prostate lesions had an average value of 11.51 (range 6.90-21.49). SUVmean in prostate lesions had an average value of 7.59 (range 5.26-14.02). CONCLUSION This pilot study indicates that pre-surgery 18F-JK-PSMA-7 PET/CT provides valuable information in intermediate- and high-risk PCa, for surgery planning with curative intent.
Collapse
Affiliation(s)
- Irina Vierasu
- grid.4989.c0000 0001 2348 0746Nuclear Medicine Department & PET/Biomedical Cyclotron Unit, Hôpital Erasme, Université libre de Bruxelles (ULB), Route de Lennik 808, 1070 Brussels, Belgium
| | - Gaetan Van Simaeys
- grid.4989.c0000 0001 2348 0746Nuclear Medicine Department & PET/Biomedical Cyclotron Unit, Hôpital Erasme, Université libre de Bruxelles (ULB), Route de Lennik 808, 1070 Brussels, Belgium ,grid.4989.c0000 0001 2348 0746Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), Charleroi, Gosselies, Belgium
| | - Nicola Trotta
- grid.4989.c0000 0001 2348 0746Nuclear Medicine Department & PET/Biomedical Cyclotron Unit, Hôpital Erasme, Université libre de Bruxelles (ULB), Route de Lennik 808, 1070 Brussels, Belgium
| | - Simon Lacroix
- grid.4989.c0000 0001 2348 0746Nuclear Medicine Department & PET/Biomedical Cyclotron Unit, Hôpital Erasme, Université libre de Bruxelles (ULB), Route de Lennik 808, 1070 Brussels, Belgium ,grid.4989.c0000 0001 2348 0746Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), Charleroi, Gosselies, Belgium
| | - Guy Bormans
- grid.5596.f0000 0001 0668 7884Radiopharmaceutical Recherche, KU Leuven, Leuven, Belgium
| | - Simone Albisinni
- grid.4989.c0000 0001 2348 0746Urology Department, Cliniques Universitaires de Bruxelles, HUB, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Thierry Quackels
- grid.4989.c0000 0001 2348 0746Urology Department, Cliniques Universitaires de Bruxelles, HUB, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Thierry Roumeguère
- grid.4989.c0000 0001 2348 0746Urology Department, Cliniques Universitaires de Bruxelles, HUB, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Serge Goldman
- grid.4989.c0000 0001 2348 0746Nuclear Medicine Department & PET/Biomedical Cyclotron Unit, Hôpital Erasme, Université libre de Bruxelles (ULB), Route de Lennik 808, 1070 Brussels, Belgium ,grid.4989.c0000 0001 2348 0746Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), Charleroi, Gosselies, Belgium
| |
Collapse
|
9
|
Niesen M, Bourguignon M, Bertels J, Vander Ghinst M, Wens V, Goldman S, De Tiège X. Cortical tracking of lexical speech units in a multi-talker background is immature in school-aged children. Neuroimage 2023; 265:119770. [PMID: 36462732 DOI: 10.1016/j.neuroimage.2022.119770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Revised: 11/09/2022] [Accepted: 11/23/2022] [Indexed: 12/03/2022] Open
Abstract
Children have more difficulty perceiving speech in noise than adults. Whether this difficulty relates to an immature processing of prosodic or linguistic elements of the attended speech is still unclear. To address the impact of noise on linguistic processing per se, we assessed how babble noise impacts the cortical tracking of intelligible speech devoid of prosody in school-aged children and adults. Twenty adults and twenty children (7-9 years) listened to synthesized French monosyllabic words presented at 2.5 Hz, either randomly or in 4-word hierarchical structures wherein 2 words formed a phrase at 1.25 Hz, and 2 phrases formed a sentence at 0.625 Hz, with or without babble noise. Neuromagnetic responses to words, phrases and sentences were identified and source-localized. Children and adults displayed significant cortical tracking of words in all conditions, and of phrases and sentences only when words formed meaningful sentences. In children compared with adults, the cortical tracking was lower for all linguistic units in conditions without noise. In the presence of noise, the cortical tracking was similarly reduced for sentence units in both groups, but remained stable for phrase units. Critically, when there was noise, adults increased the cortical tracking of monosyllabic words in the inferior frontal gyri and supratemporal auditory cortices but children did not. This study demonstrates that the difficulties of school-aged children in understanding speech in a multi-talker background might be partly due to an immature tracking of lexical but not supra-lexical linguistic units.
Collapse
Affiliation(s)
- Maxime Niesen
- Université libre de Bruxelles (ULB), UNI - ULB Neurosciences Institute, Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles (LN2T), 1070 Brussels, Belgium; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Otorhinolaryngology, 1070 Brussels, Belgium.
| | - Mathieu Bourguignon
- Université libre de Bruxelles (ULB), UNI - ULB Neurosciences Institute, Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles (LN2T), 1070 Brussels, Belgium; Université libre de Bruxelles (ULB), UNI-ULB Neuroscience Institute, Laboratory of Neurophysiology and Movement Biomechanics, 1070 Brussels, Belgium.; BCBL, Basque Center on Cognition, Brain and Language, 20009 San Sebastian, Spain
| | - Julie Bertels
- Université libre de Bruxelles (ULB), UNI - ULB Neurosciences Institute, Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles (LN2T), 1070 Brussels, Belgium; Université libre de Bruxelles (ULB), UNI-ULB Neuroscience Institute, Cognition and Computation group, ULBabyLab - Consciousness, Brussels, Belgium
| | - Marc Vander Ghinst
- Université libre de Bruxelles (ULB), UNI - ULB Neurosciences Institute, Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles (LN2T), 1070 Brussels, Belgium; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Otorhinolaryngology, 1070 Brussels, Belgium
| | - Vincent Wens
- Université libre de Bruxelles (ULB), UNI - ULB Neurosciences Institute, Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles (LN2T), 1070 Brussels, Belgium; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of translational Neuroimaging, 1070 Brussels, Belgium
| | - Serge Goldman
- Université libre de Bruxelles (ULB), UNI - ULB Neurosciences Institute, Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles (LN2T), 1070 Brussels, Belgium; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of Nuclear Medicine, 1070 Brussels, Belgium
| | - Xavier De Tiège
- Université libre de Bruxelles (ULB), UNI - ULB Neurosciences Institute, Laboratoire de Neuroanatomie et de Neuroimagerie translationnelles (LN2T), 1070 Brussels, Belgium; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, Department of translational Neuroimaging, 1070 Brussels, Belgium
| |
Collapse
|
10
|
Trotta N, Collette B, Mathey C, Vierasu I, Bucalau AM, Verset G, Moreno-Reyes R, Goldman S. Comparison of PMT-based TF64 and SiPM-based Vereos PET/CT systems for 90 Y imaging and dosimetry optimization: A quantitative study. Med Phys 2022; 49:7567-7582. [PMID: 35894818 DOI: 10.1002/mp.15880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Revised: 05/26/2022] [Accepted: 07/15/2022] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND Selective internal radiotherapy based on transarterial radioembolization (TARE) with yttrium-90 (90 Y) microspheres is an established treatment for primary or metastatic liver disease. PURPOSE The objective of this work is to optimize the dosimetry of patients treated with 90 Y TARE, using positron emission tomography (PET) images. METHODS The NEMA 2012 PET phantom was filled with nearly 3.9 GBq of 90 Y activity and acquired at days 0, 3, 5, 7, and 9 on a classic time-of-flight PET/computed tomography (CT) scanner (Philips TF64) and on a silicon photomultiplier (SiPM)-based PET/CT scanner (Philips Vereos). Acquisitions were carried on following the guidelines proposed in a previously published multicentric trial and images were reconstructed by varying and combining the available parameters. Comparisons were performed to identify the best set(s) of parameters leading to the most accurate 90 Y-PET image(s), in terms of activity distribution. Then, for both scanners, the best images were analyzed with Simplicit90 Y, a personalized dosimetry software using multicompartmental Medical Internal Radiation Dose model. The comparison between measured and true doses allowed to identify the image granting the most consistent dose estimations and, therefore, to designate the set of parameters to be applied on patients' data for the reconstruction of optimized clinical images. Posttreatment dosimetry of four patients was then realized with Simplicit90 Y using optimized imaging datasets. RESULTS Based on activity distribution comparisons and dose estimations over phantom and patients data, the SiPM-based PET/CT system appeared more suitable than the photomultiplier tube-based TF64 for 90 Y-PET imaging. With the SiPM-based PET/CT system, reconstructed images with a 2-mm voxel size combined with the application of the point spread function correction led to the most accurate results for quantitative 90 Y measures. CONCLUSIONS For the SiPM-based PET/CT scanner, an optimized set of reconstruction parameters has been identified and applied on patients' data in order to generate the most accurate image to be used for an improved personalized 90 Y-PET dosimetry, ensuring a reliable evaluation of the delivered doses.
Collapse
Affiliation(s)
- Nicola Trotta
- Department, of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Benoît Collette
- Department, of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Céline Mathey
- Department, of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Irina Vierasu
- Department, of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Ana-Maria Bucalau
- Department of Gastroenterology, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Gontran Verset
- Department of Gastroenterology, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Rodrigo Moreno-Reyes
- Department, of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Serge Goldman
- Department, of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| |
Collapse
|
11
|
Romitti M, Tourneur A, de Faria da Fonseca B, Doumont G, Gillotay P, Liao XH, Eski SE, Van Simaeys G, Chomette L, Lasolle H, Monestier O, Kasprzyk DF, Detours V, Singh SP, Goldman S, Refetoff S, Costagliola S. Transplantable human thyroid organoids generated from embryonic stem cells to rescue hypothyroidism. Nat Commun 2022; 13:7057. [PMID: 36396935 PMCID: PMC9672394 DOI: 10.1038/s41467-022-34776-7] [Citation(s) in RCA: 18] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Accepted: 11/04/2022] [Indexed: 11/18/2022] Open
Abstract
The thyroid gland captures iodide in order to synthesize hormones that act on almost all tissues and are essential for normal growth and metabolism. Low plasma levels of thyroid hormones lead to hypothyroidism, which is one of the most common disorder in humans and is not always satisfactorily treated by lifelong hormone replacement. Therefore, in addition to the lack of in vitro tractable models to study human thyroid development, differentiation and maturation, functional human thyroid organoids could pave the way to explore new therapeutic approaches. Here we report the generation of transplantable thyroid organoids derived from human embryonic stem cells capable of restoring plasma thyroid hormone in athyreotic mice as a proof of concept for future therapeutic development.
Collapse
Affiliation(s)
- Mírian Romitti
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Adrien Tourneur
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Barbara de Faria da Fonseca
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Gilles Doumont
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), Charleroi (Gosselies), Belgium
| | - Pierre Gillotay
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Xiao-Hui Liao
- Departments of Medicine, The University of Chicago, Chicago, IL, USA
| | - Sema Elif Eski
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Gaetan Van Simaeys
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), Charleroi (Gosselies), Belgium
- Service de Médecine Nucléaire, Hôpital Érasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Laura Chomette
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Helene Lasolle
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Olivier Monestier
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Dominika Figini Kasprzyk
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Vincent Detours
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Sumeet Pal Singh
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Serge Goldman
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), Charleroi (Gosselies), Belgium
- Service de Médecine Nucléaire, Hôpital Érasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Samuel Refetoff
- Departments of Medicine, The University of Chicago, Chicago, IL, USA
- Departments of Medicine, Pediatrics and Committee on Genetics, The University of Chicago, Chicago, IL, USA
| | - Sabine Costagliola
- Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium.
| |
Collapse
|
12
|
Hochberg J, Xavier A, Audino A, Barth M, Miles R, Kahwash S, Voss S, Braniecki S, Moorthy C, Armenian S, Ehrhardt M, Lim M, Harrison L, Goldman S, Cairo M. REDUCING THE BURDEN OF ONCOLOGY CHEMORADIOTHERAPY AND RADIATION EXPOSURE FROM DIAGNOSTIC IMAGING BY UTILIZING TARGETED IMMUNOTHERAPY IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMA (RADICAL, HODGKIN LYMPHOMA COHORT. Leuk Res 2022. [DOI: 10.1016/s0145-2126(22)00209-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
13
|
Audino A, Xavier A, Hochberg J, Barth M, Miles R, Kahwash S, Voss S, Braniecki S, Moorthy C, Armenian S, Ehrhardt M, Lim M, Harrison L, Goldman S, Cairo M. REDUCING CHEMORADIOTHERAPY AND RADIATION EXPOSURE FROM DIAGNOSTIC IMAGING BY UTILIZING TARGED IMMUNOTHERAPY IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS (CAYA) WITH MATURE LARGE B-CELL LYMPHOMA (RADICAL). Leuk Res 2022. [DOI: 10.1016/s0145-2126(22)00250-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
14
|
Coppola A, Izumoto S, Rodríguez-Osorio X, Wu T, D’Souza W, Maschio M, Goldman S, Valente Fernandes M, Villanueva V. P11.08.A Clinical practice evidence for perampanel in epilepsy patients with tumour aetiology. Neuro Oncol 2022. [DOI: 10.1093/neuonc/noac174.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Real-world studies can provide information on those patients routinely excluded from clinical trials such as epilepsy patients with tumour aetiology. Perampanel (PER) is a once-daily oral anti-seizure medication for focal-onset seizures, with or without focal to bilateral tonic-clonic seizures, and generalised tonic-clonic seizures. This study evaluated PER’s effectiveness and safety when used in everyday clinical practice to treat epilepsy patients with tumour aetiology.
Material and Methods
Patients with epilepsy with tumour aetiology were identified from a pooled analysis of 44 prospective/retrospective/cross-sectional clinical practice studies. Retention was assessed after 3, 6 and 12 months of PER treatment. Effectiveness assessments comprised responder rate (≥50% seizure frequency reduction), seizure freedom rate (no seizures since at least the prior visit), and the proportions of patients with unchanged or worsening seizure frequency. Adverse events (AEs), psychiatric AEs, and AEs leading to discontinuation were also evaluated.
Results
Overall, 127 patients with focal-onset and/or generalised-onset seizures with tumour aetiology were identified (mean age, 46.6 years; 54.8% male; mean duration of epilepsy, 9.7 years). Seizure types at baseline were focal-onset only (97.6%), generalised-onset only (1.6%), and focal-onset and generalized-onset (0.8%). Mean (standard deviation) PER doses at baseline and last visit were 2.6 (1.4) and 5.8 (2.5) mg/day, respectively. At 3, 6 and 12 months, retention rates were 88.0%, 79.5% and 65.3%, respectively. Reasons for discontinuation included AEs (16.8%) and lack of efficacy (5.3%). Mean time under PER treatment was 11.0 months. At 12 months, 71.2% of patients were responders and 38.3% were seizure free; 11.9% and 3.4% of patients had unchanged and worsening seizure frequency, respectively. At the last visit (last observation carried forward), responder and seizure freedom rates were 66.9% and 34.2%, respectively, and the percentages of patients with unchanged or worsening seizure frequency were 15.3% and 6.8%, respectively. AEs were reported for 36.2% of patients, most frequently dizziness/vertigo (13.8%) and somnolence (9.5%). AEs led to discontinuation of 16.8% of patients over 12 months and 13.0% of patients experienced psychiatric AEs.
Conclusion
PER was effective and generally well tolerated when used to treat patients with epilepsy with tumour aetiology in clinical practice. Supported by Eisai
Collapse
Affiliation(s)
- A Coppola
- Epilepsy Centre, Department of Neuroscience, Odontostomatological and Reproductive Sciences, Federico II University of Naples , Naples , Italy
| | - S Izumoto
- Department of Neurosurgery, Kindai University , Osaka-Sayama , Japan
| | - X Rodríguez-Osorio
- Department of Neurology, Complexo Hospitalario Universitario de Santiago , Santiago , Spain
| | - T Wu
- Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University College of Medicine , Taoyuan , Taiwan
| | - W D’Souza
- Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne , Melbourne , Australia
| | - M Maschio
- Center for Brain Tumor-Related Epilepsy, UOSD Neuro-Oncology, I.R.C.C.S. Regina Elena National Cancer Institute , Rome , Italy
| | - S Goldman
- Eisai Europe Ltd , Hatfield , United Kingdom
| | - M Valente Fernandes
- Neurology Department, Instituto Português de Oncologia de Lisboa , Lisbon , Portugal
| | - V Villanueva
- Refractory Epilepsy Unit, Hospital Universitario y Politécnico La Fe , Valencia , Spain
| |
Collapse
|
15
|
Bastide L, Perrotta G, Lolli V, Mathey C, Vierasu OI, Goldman S, Vandergheynst F. Atypical acute disseminated encephalomyelitis with systemic inflammation after a first dose of AztraZaneca COVID-19 vaccine. A case report. Front Neurol 2022; 13:995875. [PMID: 36105772 PMCID: PMC9465085 DOI: 10.3389/fneur.2022.995875] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Accepted: 08/11/2022] [Indexed: 12/12/2022] Open
Abstract
Background Only a few cases of acute disseminated encephalomyelitis (ADEM) following coronavirus disease 19 (COVID-19) vaccination have been described since the beginning of the vaccination campaign. Results Here we report the first case of central nervous system (CNS) demyelination with systemic inflammatory findings on whole body 19-fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET/CT) following the ChAdOx1 nCoV-19 vaccine. Conclusions Clinicians should stay aware of potential new adverse events after immunization.
Collapse
Affiliation(s)
- Laure Bastide
- Department of Neurology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
- *Correspondence: Laure Bastide
| | - Gaetano Perrotta
- Department of Neurology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Valentina Lolli
- Department of Radiology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Céline Mathey
- Department of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Ortensa-Irina Vierasu
- Department of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Serge Goldman
- Department of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Frédéric Vandergheynst
- Department of Internal Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| |
Collapse
|
16
|
Martens C, Rovai A, Bonatto D, Metens T, Debeir O, Decaestecker C, Goldman S, Van Simaeys G. Deep Learning for Reaction-Diffusion Glioma Growth Modeling: Towards a Fully Personalized Model? Cancers (Basel) 2022; 14:cancers14102530. [PMID: 35626134 PMCID: PMC9139770 DOI: 10.3390/cancers14102530] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Revised: 05/11/2022] [Accepted: 05/18/2022] [Indexed: 11/30/2022] Open
Abstract
Simple Summary Mathematical tumor growth models have been proposed for decades to capture the growth of gliomas, an aggressive form of brain tumor. However, the estimation of the tumor cell-density distribution at diagnosis and model parameters from partial observations provided by magnetic resonance imaging are ill-posed problems. In this work, we propose a deep learning-based approach to address these problems. 1200 synthetic tumors are first generated using the mathematical model over brain geometries of 6 volunteers. Two deep convolutional neural networks are then trained to (i) reconstruct a whole tumor cell-density distribution and (ii) evaluate the model parameters from partial observations provided in the form of threshold-like imaging contours, with state-of-the-art results. From the estimated cell-density distribution and parameter values, the spatio-temporal evolution of the tumor can ultimately be accurately captured by the mathematical model. Such an approach could be of great interest for glioma characterization and therapy planning. Abstract Reaction-diffusion models have been proposed for decades to capture the growth of gliomas, the most common primary brain tumors. However, ill-posedness of the initialization at diagnosis time and parameter estimation of such models have restrained their clinical use as a personalized predictive tool. In this work, we investigate the ability of deep convolutional neural networks (DCNNs) to address commonly encountered pitfalls in the field. Based on 1200 synthetic tumors grown over real brain geometries derived from magnetic resonance (MR) data of six healthy subjects, we demonstrate the ability of DCNNs to reconstruct a whole tumor cell-density distribution from only two imaging contours at a single time point. With an additional imaging contour extracted at a prior time point, we also demonstrate the ability of DCNNs to accurately estimate the individual diffusivity and proliferation parameters of the model. From this knowledge, the spatio-temporal evolution of the tumor cell-density distribution at later time points can ultimately be precisely captured using the model. We finally show the applicability of our approach to MR data of a real glioblastoma patient. This approach may open the perspective of a clinical application of reaction-diffusion growth models for tumor prognosis and treatment planning.
Collapse
Affiliation(s)
- Corentin Martens
- Department of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (A.R.); (S.G.); (G.V.S.)
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (O.D.); (C.D.)
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (D.B.); (T.M.)
- Correspondence:
| | - Antonin Rovai
- Department of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (A.R.); (S.G.); (G.V.S.)
| | - Daniele Bonatto
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (D.B.); (T.M.)
| | - Thierry Metens
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (D.B.); (T.M.)
- Department of Radiology, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium
| | - Olivier Debeir
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (O.D.); (C.D.)
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (D.B.); (T.M.)
| | - Christine Decaestecker
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (O.D.); (C.D.)
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (D.B.); (T.M.)
| | - Serge Goldman
- Department of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (A.R.); (S.G.); (G.V.S.)
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (O.D.); (C.D.)
| | - Gaetan Van Simaeys
- Department of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (A.R.); (S.G.); (G.V.S.)
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (O.D.); (C.D.)
| |
Collapse
|
17
|
Castiaux A, Vierasu I, Vandergheynst F, Goldman S. Recurrent 'Occult' 18F-FDG Uptake in an Atypical Case of Anti-Myeloperoxidase Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Eur J Case Rep Intern Med 2022; 9:003330. [PMID: 35774741 PMCID: PMC9239030 DOI: 10.12890/2022_003330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2022] [Accepted: 04/19/2022] [Indexed: 11/07/2022] Open
Abstract
A 72-year-old woman, with anti-myeloperoxidase antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), presented with two episodes of spinal pachymeningitis (at two different levels 9 years apart, cervical in 2011 and dorso-lumbar in 2020) associated with aortitis and only demonstrated by F-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). This association between aortitis and pachymeningitis in AAV appears exceptional. Moreover, the relapse of aortitis and pachymeningitis in 2020 was not accompanied by an increase in ANCA. This case demonstrates the value of 18F-FDG PET/CT in the management of AAV, providing evidence of the recurrence and distribution of lesions in various organs, including those with unexpected involvement. LEARNING POINTS Involvement of large vessels such as the aorta is rarely associated with anti-myeloperoxidase antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), but has been described in a few cases. Possible aortic involvement should always be kept in mind while managing a patient with AAV.Pachymeningitis is rarely associated with AAV, but in case of unexplained and unspecific neurological symptoms in patients with AAV, such involvement should be considered.18F-FDG PET/CT is a promising tool for the management of patients with AAV, allowing unexpected sites, undetected by usual examinations, to be highlighted. In contrast to giant-cell arteritis, this exam has not, until now, been included in the recommended/systematic work-up of AAV.
Collapse
Affiliation(s)
- Amélie Castiaux
- Department of Nuclear Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
| | - Irina Vierasu
- Department of Nuclear Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
| | - Frederic Vandergheynst
- Department of Internal Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
| | - Serge Goldman
- Department of Nuclear Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
| |
Collapse
|
18
|
Feys O, Corvilain P, Aeby A, Sculier C, Holmes N, Brookes M, Goldman S, Wens V, De Tiège X. On-Scalp Optically Pumped Magnetometers versus Cryogenic Magnetoencephalography for Diagnostic Evaluation of Epilepsy in School-aged Children. Radiology 2022; 304:429-434. [PMID: 35503013 DOI: 10.1148/radiol.212453] [Citation(s) in RCA: 32] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Background Magnetoencephalography (MEG) is an established method used to detect and localize focal interictal epileptiform discharges (IEDs). Current MEG systems house hundreds of cryogenic sensors in a rigid, one-size-fits-all helmet, which results in several limitations, particularly in children. Purpose To determine if on-scalp MEG based on optically pumped magnetometers (OPMs) alleviates the main limitations of cryogenic MEG. Materials and Methods In this prospective single-center study conducted in a tertiary university teaching hospital, participants underwent cryogenic (102 magnetometers, 204 planar gradiometers) and on-scalp (32 OPMs) MEG. The two modalities for the detection and localization of IEDs were compared. The t test was used to compare IED amplitude and signal-to-noise ratio (SNR). Distributed source modeling was performed on OPM-based and cryogenic MEG data. Results Five children (median age, 9.4 years [range, 5-11 years]; four girls) with self-limited idiopathic (n = 3) or refractory (n = 2) focal epilepsy were included. IEDs were identified in all five children with comparable sensor topographies for both MEG devices. IED amplitudes were 2.3 (7.2 of 3.1) to 4.6 (3.2 of 0.7) times higher (P < .001) with on-scalp MEG, and the SNR was 27% (16.7 of 13.2) to 60% (12.8 of 8.0) higher (P value range: .001-.009) with on-scalp MEG in all but one participant (P = .93), whose head movements created pronounced motion artifacts. The neural source of averaged IEDs was located at approximately 5 mm (n = 3) or higher (8.3 mm, n = 1; 15.6 mm, n = 1) between on-scalp and cryogenic MEG. Conclusion Despite the limited number of sensors and scalp coverage, on-scalp magnetoencephalography (MEG) based on optically pumped magnetometers helped detect interictal epileptiform discharges in school-aged children with epilepsy with a higher amplitude, higher signal-to-noise ratio, and similar localization value compared with conventional cryogenic MEG. Online supplemental material is available for this article. © RSNA, 2022 See also the editorial by Widjaja in this issue.
Collapse
Affiliation(s)
- Odile Feys
- From the Departments of Neurology (O.F.), Pediatric Neurology (C.S., F.C.), Nuclear Medicine (S.G.), and Translational Neuroimaging (V.W., X.D.T.), CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Translational Neuroimaging and Neuroanatomy (Laboratoire de Neuroimagerie et Neuroanatomie translationnelles) (LNT), ULB Neuroscience Institute, Université Libre de Bruxelles, 808 Lennik St, Brussels, Belgium (O.F., P.C., S.G., V.W., X.D.T.); Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium (A.A.); and Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom (N.H., M.B.)
| | - Pierre Corvilain
- From the Departments of Neurology (O.F.), Pediatric Neurology (C.S., F.C.), Nuclear Medicine (S.G.), and Translational Neuroimaging (V.W., X.D.T.), CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Translational Neuroimaging and Neuroanatomy (Laboratoire de Neuroimagerie et Neuroanatomie translationnelles) (LNT), ULB Neuroscience Institute, Université Libre de Bruxelles, 808 Lennik St, Brussels, Belgium (O.F., P.C., S.G., V.W., X.D.T.); Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium (A.A.); and Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom (N.H., M.B.)
| | - Alec Aeby
- From the Departments of Neurology (O.F.), Pediatric Neurology (C.S., F.C.), Nuclear Medicine (S.G.), and Translational Neuroimaging (V.W., X.D.T.), CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Translational Neuroimaging and Neuroanatomy (Laboratoire de Neuroimagerie et Neuroanatomie translationnelles) (LNT), ULB Neuroscience Institute, Université Libre de Bruxelles, 808 Lennik St, Brussels, Belgium (O.F., P.C., S.G., V.W., X.D.T.); Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium (A.A.); and Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom (N.H., M.B.)
| | - Claudine Sculier
- From the Departments of Neurology (O.F.), Pediatric Neurology (C.S., F.C.), Nuclear Medicine (S.G.), and Translational Neuroimaging (V.W., X.D.T.), CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Translational Neuroimaging and Neuroanatomy (Laboratoire de Neuroimagerie et Neuroanatomie translationnelles) (LNT), ULB Neuroscience Institute, Université Libre de Bruxelles, 808 Lennik St, Brussels, Belgium (O.F., P.C., S.G., V.W., X.D.T.); Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium (A.A.); and Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom (N.H., M.B.)
| | - Niall Holmes
- From the Departments of Neurology (O.F.), Pediatric Neurology (C.S., F.C.), Nuclear Medicine (S.G.), and Translational Neuroimaging (V.W., X.D.T.), CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Translational Neuroimaging and Neuroanatomy (Laboratoire de Neuroimagerie et Neuroanatomie translationnelles) (LNT), ULB Neuroscience Institute, Université Libre de Bruxelles, 808 Lennik St, Brussels, Belgium (O.F., P.C., S.G., V.W., X.D.T.); Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium (A.A.); and Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom (N.H., M.B.)
| | - Matthew Brookes
- From the Departments of Neurology (O.F.), Pediatric Neurology (C.S., F.C.), Nuclear Medicine (S.G.), and Translational Neuroimaging (V.W., X.D.T.), CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Translational Neuroimaging and Neuroanatomy (Laboratoire de Neuroimagerie et Neuroanatomie translationnelles) (LNT), ULB Neuroscience Institute, Université Libre de Bruxelles, 808 Lennik St, Brussels, Belgium (O.F., P.C., S.G., V.W., X.D.T.); Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium (A.A.); and Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom (N.H., M.B.)
| | - Serge Goldman
- From the Departments of Neurology (O.F.), Pediatric Neurology (C.S., F.C.), Nuclear Medicine (S.G.), and Translational Neuroimaging (V.W., X.D.T.), CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Translational Neuroimaging and Neuroanatomy (Laboratoire de Neuroimagerie et Neuroanatomie translationnelles) (LNT), ULB Neuroscience Institute, Université Libre de Bruxelles, 808 Lennik St, Brussels, Belgium (O.F., P.C., S.G., V.W., X.D.T.); Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium (A.A.); and Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom (N.H., M.B.)
| | - Vincent Wens
- From the Departments of Neurology (O.F.), Pediatric Neurology (C.S., F.C.), Nuclear Medicine (S.G.), and Translational Neuroimaging (V.W., X.D.T.), CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Translational Neuroimaging and Neuroanatomy (Laboratoire de Neuroimagerie et Neuroanatomie translationnelles) (LNT), ULB Neuroscience Institute, Université Libre de Bruxelles, 808 Lennik St, Brussels, Belgium (O.F., P.C., S.G., V.W., X.D.T.); Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium (A.A.); and Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom (N.H., M.B.)
| | - Xavier De Tiège
- From the Departments of Neurology (O.F.), Pediatric Neurology (C.S., F.C.), Nuclear Medicine (S.G.), and Translational Neuroimaging (V.W., X.D.T.), CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Translational Neuroimaging and Neuroanatomy (Laboratoire de Neuroimagerie et Neuroanatomie translationnelles) (LNT), ULB Neuroscience Institute, Université Libre de Bruxelles, 808 Lennik St, Brussels, Belgium (O.F., P.C., S.G., V.W., X.D.T.); Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium (A.A.); and Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom (N.H., M.B.)
| |
Collapse
|
19
|
Vierasu I, Trotta N, Albisinni S, Mathey C, Leurquin-Sterk G, Lacroix S, Van Simaeys G, Quackels T, Roumeguère T, Goldman S. Clinical experience with 18F-JK-PSMA-7 when using a digital PET/CT. Eur J Hybrid Imaging 2022; 6:6. [PMID: 35288807 PMCID: PMC8921393 DOI: 10.1186/s41824-022-00128-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Accepted: 01/21/2022] [Indexed: 11/20/2022] Open
Abstract
Background Digital PET/CT systems make use of a new technology with higher sensitivity and other better technological features than the analog ones. They require adaptation of the trade-off between performance, tracer dose and acquisition time. The aim of the study was to explore the performance of 18F-JK-PSMA-7 imaging when performed on a digital PET/CT with an adapted protocol, in a population of patients with prostate cancer patients (PCa). Influence of previous therapy on PET/CT performance is generally disregarded in PSMA-based imaging, despite potential influence of hormono-chemotherapy on the target expression. This potential influence was also tested in this work. Methods A total of 54 PCa patients experiencing biochemical recurrence were included in the study, in which we analysed the diagnostic performance of digital 18F-JK-PSMA-7 PET/CT. Compared to our protocol applied for acquisition on an analog system, administered dose and acquisition time were reduced by 20% and 50% respectively. We specifically took into consideration the influence of previous treatments on recurrence detection. Results We detected overall 18F-JK-PSMA-7-positive lesions in 38/54 patients (70.3%). There was no statistically significant difference regarding the detection rate between the groups of patients who had hormono-chemotherapy any time after initial diagnosis and those who never got any hormonal or chemotherapeutic treatment. Regarding the SUV max values, there was not significant difference between the two groups of patients neither in pelvic ganglions nor in other metastatic sites or the prostate region. Conclusion 18F-JK-PSMA7 PET/CT with administered dose and acquisition time adapted to the digital technology provides valuable information in PCa patients with biochemical recurrence.
Collapse
|
20
|
Van Dyck D, Deconinck N, Aeby A, Baijot S, Coquelet N, Trotta N, Rovai A, Goldman S, Urbain C, Wens V, De Tiège X. Atypical resting-state functional brain connectivity in children with developmental coordination disorder. Neuroimage Clin 2022; 33:102928. [PMID: 34959048 PMCID: PMC8856907 DOI: 10.1016/j.nicl.2021.102928] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2021] [Revised: 12/06/2021] [Accepted: 12/22/2021] [Indexed: 12/21/2022]
Abstract
Atypical connectivity in children with developmental coordination disorder. Stronger connectivity mainly found within the dorsal extrastriate network. May reflect a brain trait of children with developmental coordination disorder. This atypical connectivity is not associated with motor/visual perceptual abilities. Lower visuomotor performance associated with stronger sensorimotor connectivity.
Children with developmental coordination disorder (DCD) present lower abilities to acquire and execute coordinated motor skills. DCD is frequently associated with visual perceptual (with or without motor component) impairments. This magnetoencephalography (MEG) study compares the brain resting-state functional connectivity (rsFC) and spectral power of children with and without DCD. 29 children with DCD and 28 typically developing (TD) peers underwent 2 × 5 min of resting-state MEG. Band-limited power envelope correlation and spectral power were compared between groups using a functional connectome of 59 nodes from eight resting-state networks. Correlation coefficients were calculated between fine and gross motor activity, visual perceptual and visuomotor abilities measures on the one hand, and brain rsFC and spectral power on the other hand. Nonparametric statistics were used. Significantly higher rsFC between nodes of the visual, attentional, frontoparietal, default-mode and cerebellar networks was observed in the alpha (maximum statistics, p = .0012) and the low beta (p = .0002) bands in children with DCD compared to TD peers. Lower visuomotor performance (copying figures) was associated with stronger interhemispheric rsFC within sensorimotor areas and power in the cerebellum (right lobule VIII). Children with DCD showed increased rsFC mainly in the dorsal extrastriate visual brain system and the cerebellum. However, this increase was not associated with their coordinated motor/visual perceptual abilities. This enhanced functional brain connectivity could thus reflect a characteristic brain trait of children with DCD compared to their TD peers. Moreover, an interhemispheric compensatory process might be at play to perform visuomotor task within the normative range.
Collapse
Affiliation(s)
- Dorine Van Dyck
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université libre de Bruxelles (ULB), Brussels, Belgium.
| | - Nicolas Deconinck
- Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Alec Aeby
- Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université libre de Bruxelles (ULB), Brussels, Belgium; Neuropsychology and Functional Neuroimaging Research Group (UR2NF) at Center for Research in Cognition and Neurosciences (CRCN) and ULB Neurosciences Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Simon Baijot
- Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université libre de Bruxelles (ULB), Brussels, Belgium; Neuropsychology and Functional Neuroimaging Research Group (UR2NF) at Center for Research in Cognition and Neurosciences (CRCN) and ULB Neurosciences Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Nicolas Coquelet
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Nicola Trotta
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Clinics of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Antonin Rovai
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Clinics of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Serge Goldman
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Clinics of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Charline Urbain
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Neuropsychology and Functional Neuroimaging Research Group (UR2NF) at Center for Research in Cognition and Neurosciences (CRCN) and ULB Neurosciences Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Vincent Wens
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Clinics of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Xavier De Tiège
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Clinics of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| |
Collapse
|
21
|
Refaee T, Bondue B, Van Simaeys G, Wu G, Yan C, Woodruff HC, Goldman S, Lambin P. A Handcrafted Radiomics-Based Model for the Diagnosis of Usual Interstitial Pneumonia in Patients with Idiopathic Pulmonary Fibrosis. J Pers Med 2022; 12:jpm12030373. [PMID: 35330373 PMCID: PMC8948773 DOI: 10.3390/jpm12030373] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Revised: 02/23/2022] [Accepted: 02/26/2022] [Indexed: 02/05/2023] Open
Abstract
The most common idiopathic interstitial lung disease (ILD) is idiopathic pulmonary fibrosis (IPF). It can be identified by the presence of usual interstitial pneumonia (UIP) via high-resolution computed tomography (HRCT) or with the use of a lung biopsy. We hypothesized that a CT-based approach using handcrafted radiomics might be able to identify IPF patients with a radiological or histological UIP pattern from those with an ILD or normal lungs. A total of 328 patients from one center and two databases participated in this study. Each participant had their lungs automatically contoured and sectorized. The best radiomic features were selected for the random forest classifier and performance was assessed using the area under the receiver operator characteristics curve (AUC). A significant difference in the volume of the trachea was seen between a normal state, IPF, and non-IPF ILD. Between normal and fibrotic lungs, the AUC of the classification model was 1.0 in validation. When classifying between IPF with a typical HRCT UIP pattern and non-IPF ILD the AUC was 0.96 in validation. When classifying between IPF with UIP (radiological or biopsy-proved) and non-IPF ILD, an AUC of 0.66 was achieved in the testing dataset. Classification between normal, IPF/UIP, and other ILDs using radiomics could help discriminate between different types of ILDs via HRCT, which are hardly recognizable with visual assessments. Radiomic features could become a valuable tool for computer-aided decision-making in imaging, and reduce the need for unnecessary biopsies.
Collapse
Affiliation(s)
- Turkey Refaee
- The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6200 MD Maastricht, The Netherlands; (T.R.); (C.Y.); (H.C.W.)
- Department of Diagnostic Radiology, Faculty of Applied Medical Sciences, Jazan University, Jazan 45142, Saudi Arabia
| | - Benjamin Bondue
- Department of Pneumology, Erasme University Hospital, Université libre de Bruxelles, 1070 Brussels, Belgium;
| | - Gaetan Van Simaeys
- Department of Nuclear Medicine, Erasme University Hospital, Université libre de Bruxelles, 1070 Brussels, Belgium; (G.V.S.); (S.G.)
| | - Guangyao Wu
- Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China;
| | - Chenggong Yan
- The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6200 MD Maastricht, The Netherlands; (T.R.); (C.Y.); (H.C.W.)
- Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - Henry C. Woodruff
- The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6200 MD Maastricht, The Netherlands; (T.R.); (C.Y.); (H.C.W.)
- Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, 6200 MD Maastricht, The Netherlands
| | - Serge Goldman
- Department of Nuclear Medicine, Erasme University Hospital, Université libre de Bruxelles, 1070 Brussels, Belgium; (G.V.S.); (S.G.)
| | - Philippe Lambin
- The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6200 MD Maastricht, The Netherlands; (T.R.); (C.Y.); (H.C.W.)
- Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, 6200 MD Maastricht, The Netherlands
- Correspondence:
| |
Collapse
|
22
|
Belcour M, Dontaine P, Monier A, Lebrun L, Salmon I, De Witte O, Goldman S, De Tiège X, Aeby A. Case Report: Interest of Positron Emission Tomography in Pediatric Small Vessel Primary Angiitis of the Central Nervous System. Front Pediatr 2022; 10:794294. [PMID: 35321014 PMCID: PMC8935040 DOI: 10.3389/fped.2022.794294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/13/2021] [Accepted: 01/24/2022] [Indexed: 11/13/2022] Open
Abstract
Primary angiitis of the central nervous system (PACNS) is a rare inflammatory disease affecting central nervous system vessels. The diagnosis, which requires confirmation by brain biopsy, remains challenging due to unspecific clinical presentation and low specificity of imaging and laboratory exams. In these two pediatric biopsy-proven cases of svPACNS we demonstrate that brain positron emission tomography (PET) show a high metabolic activity that extends beyond brain MRI abnormalities. Therefore, combining MRI and PET abnormalities to adequately guide brain biopsy might increase the diagnostic yield of this rare condition.
Collapse
Affiliation(s)
- Morgane Belcour
- Department of Pediatrics, Hôpital des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Pauline Dontaine
- Department of Pediatric Neurology, Université Libre de Bruxelles - Hôpital Universitaire Des Enfants Reine Fabiola (ULB-HUDERF), Brussels, Belgium
| | - Anne Monier
- Department of Pediatric Neurology, Université Libre de Bruxelles - Hôpital Universitaire Des Enfants Reine Fabiola (ULB-HUDERF), Brussels, Belgium
| | - Laetitia Lebrun
- Department of Anatomopathology, Cliniques Universitaires de Bruxelles (CUB) Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Isabelle Salmon
- Department of Anatomopathology, Cliniques Universitaires de Bruxelles (CUB) Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Olivier De Witte
- Department of Neurosurgery, Cliniques Universitaires de Bruxelles (CUB) Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Serge Goldman
- Department of Functional Neuroimaging, Service of Nuclear Medicine, Cliniques Universitaires de Bruxelles (CUB) Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Xavier De Tiège
- Department of Functional Neuroimaging, Service of Nuclear Medicine, Cliniques Universitaires de Bruxelles (CUB) Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Alec Aeby
- Department of Pediatric Neurology, Université Libre de Bruxelles - Hôpital Universitaire Des Enfants Reine Fabiola (ULB-HUDERF), Brussels, Belgium
| |
Collapse
|
23
|
Van Bogaert C, Vierasu I, Mathey C, Theunissen A, Goldman S. Bilateral cytomegalovirus infection of the adrenal glands revealed by 18F-FDG PET/CT in a patient with T-cell lymphoma. Clin Case Rep 2022; 10:e05005. [PMID: 35127088 PMCID: PMC8795922 DOI: 10.1002/ccr3.5005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2021] [Revised: 10/04/2021] [Accepted: 10/10/2021] [Indexed: 12/26/2022] Open
Abstract
This case report demonstrates the possible subclinical adrenal and pancreatic involvement in immunocompromised patients (in particular those with lymphoma) with a CMV infection and the role of whole-body 18F-FDG PET/CT in detecting these lesions.
Collapse
Affiliation(s)
| | - Irina Vierasu
- Department of Nuclear MedicineCUB‐Hôpital ErasmeBruxellesBelgium
| | - Céline Mathey
- Department of Nuclear MedicineCUB‐Hôpital ErasmeBruxellesBelgium
| | | | - Serge Goldman
- Department of Nuclear MedicineCUB‐Hôpital ErasmeBruxellesBelgium
| |
Collapse
|
24
|
Coquelet N, De Tiège X, Roshchupkina L, Peigneux P, Goldman S, Woolrich M, Wens V. Microstates and power envelope hidden Markov modeling probe bursting brain activity at different timescales. Neuroimage 2021; 247:118850. [PMID: 34954027 PMCID: PMC8803543 DOI: 10.1016/j.neuroimage.2021.118850] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2021] [Revised: 12/20/2021] [Accepted: 12/21/2021] [Indexed: 11/29/2022] Open
Abstract
State modeling of whole-brain electroencephalography (EEG) or magnetoencephalography (MEG) allows to investigate transient, recurring neurodynamical events. Two widely-used techniques are the microstate analysis of EEG signals and hidden Markov modeling (HMM) of MEG power envelopes. Both reportedly lead to similar state lifetimes on the 100 ms timescale, suggesting a common neural basis. To investigate whether microstates and power envelope HMM states describe the same neural dynamics, we used simultaneous MEG/EEG recordings at rest and compared the spatial signature and temporal activation dynamics of microstates and power envelope HMM states obtained separately from EEG and MEG. Results showed that microstates and power envelope HMM states differ both spatially and temporally. Microstates reflect sharp events of neural synchronization, whereas power envelope HMM states disclose network-level activity with 100–200 ms lifetimes. Further, MEG microstates do not correspond to the canonical EEG microstates but are better interpreted as split HMM states. On the other hand, both MEG and EEG HMM states involve the (de)activation of similar functional networks. Microstate analysis and power envelope HMM thus appear sensitive to neural events occurring over different spatial and temporal scales. As such, they represent complementary approaches to explore the fast, sub-second scale bursting electrophysiological dynamics in spontaneous human brain activity.
Collapse
Affiliation(s)
- N Coquelet
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI - ULB Neuroscience Institute, Université libre de Bruxelles, Brussels 1070, Belgium.
| | - X De Tiège
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI - ULB Neuroscience Institute, Université libre de Bruxelles, Brussels 1070, Belgium; Magnetoencephalography Unit, Service of Translational Neuroimaging, CUB - Hôpital Erasme, Brussels, Belgium
| | - L Roshchupkina
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI - ULB Neuroscience Institute, Université libre de Bruxelles, Brussels 1070, Belgium; Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Centre for Research in Cognition and Neurosciences (CRCN), UNI - ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - P Peigneux
- Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Centre for Research in Cognition and Neurosciences (CRCN), UNI - ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - S Goldman
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI - ULB Neuroscience Institute, Université libre de Bruxelles, Brussels 1070, Belgium; Magnetoencephalography Unit, Service of Translational Neuroimaging, CUB - Hôpital Erasme, Brussels, Belgium
| | - M Woolrich
- Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, United Kingdom
| | - V Wens
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI - ULB Neuroscience Institute, Université libre de Bruxelles, Brussels 1070, Belgium; Magnetoencephalography Unit, Service of Translational Neuroimaging, CUB - Hôpital Erasme, Brussels, Belgium
| |
Collapse
|
25
|
Rzeczycki P, Rasner C, Lammlin L, Junginger L, Goldman S, Bergman R, Redding S, Knights AJ, Elliott M, Maerz T. Cannabinoid receptor type 2 is upregulated in synovium following joint injury and mediates anti-inflammatory effects in synovial fibroblasts and macrophages. Osteoarthritis Cartilage 2021; 29:1720-1731. [PMID: 34537380 PMCID: PMC8883578 DOI: 10.1016/j.joca.2021.09.003] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/11/2021] [Revised: 08/09/2021] [Accepted: 09/06/2021] [Indexed: 02/02/2023]
Abstract
OBJECTIVE Joint injury-induced perturbations to the endocannabinoid system (ECS), a regulator of both inflammation and nociception, remain largely uncharacterized. We employed a mouse model of ACL rupture to assess alterations to nociception, inflammation, and the ECS while using in vitro models to determine whether CB2 agonism can mitigate inflammatory signaling in macrophages and fibroblast-like synoviocytes (FLS). DESIGN Mice underwent noninvasive ACL rupture (ACLR) via tibial compression-based loading. Nociception was measured longitudinally using mechanical allodynia and knee hyperalgesia testing. Synovitis was assessed using histological scoring and histomorphometry. Gene and protein markers of inflammation were characterized in whole joints and synovium. Immunohistochemistry assessed injury-induced alterations to CB1+, CB2+, and F4/80+ cells in synovium. To assess whether CB2 agonism can inhibit pro-inflammatory macrophage polarization, murine bone marrow-derived macrophages (mBMDM) were stimulated with IL-1β or conditioned medium from IL-1β-treated FLS and treated with vehicle (DMSO), the CB2 agonist HU308, or cannabidiol (CBD). Macrophage polarization was assessed as the ratio of M1-associated (IL1b, MMP1b, and IL6) to M2-associated (IL10, IL4, and CD206) gene expression. Human FLS (hFLS) isolated from synovial tissue of OA patients were treated with vehicle (DMSO) or HU308 following TNF-α or IL-1β stimulation to assess inhibition of catabolic/inflammatory gene expression. RESULTS ACLR induces synovitis, progressively-worsening PTOA severity, and an immediate and sustained increase in both mechanical allodynia and knee hyperalgesia, which persist beyond the resolution of molecular inflammation. Enrichment of CB2, but not CB1, was observed in ACLR synovium at 3d, 14d, and 28d, and CB2 was found to be associated with F4/80 (+) cells, which are increased in number in ACLR synovium at all time points. The CB2 agonist HU308 strongly inhibited mBMDM M1-type polarization following stimulation with either IL-1β or conditioned medium from IL-1β-treated mFLS, which was characterized by reductions in Il1b, Mmp1b, and Il6 and increases in Cd206 gene expression. Cannabidiol similarly inhibited IL-1β-induced mBMDM M1 polarization via a reduction in Il1b and an increase in Cd206 and Il4 gene expression. Lastly, in OA hFLS, HU308 treatment inhibited IL-1β-induced CCL2, MMP1, MMP3, and IL6 expression and further inhibited TNF-α-induced CCL2, MMP1, and GMCSF expression, demonstrating human OA-relevant anti-inflammatory effects by targeting CB2. CONCLUSIONS Joint injury perturbs the intra-articular ECS, characterized by an increase in synovial F4/80(+) cells, which express CB2, but not CB1. Targeting CB2 in murine macrophages and human FLS induced potent anti-inflammatory and anti-catabolic effects, which indicates that the CB2 receptor plays a key role in regulating inflammatory signaling in the two primary effector cells in the synovium. The intraarticular ECS is therefore a potential therapeutic target for blocking pathological inflammation in future disease-modifying PTOA treatments.
Collapse
Affiliation(s)
- P Rzeczycki
- Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA
| | - C Rasner
- Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA
| | - L Lammlin
- Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA
| | - L Junginger
- Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA
| | - S Goldman
- Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA
| | - R Bergman
- Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA
| | - S Redding
- Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA
| | - A J Knights
- Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA
| | - M Elliott
- Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA
| | - T Maerz
- Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA.
| |
Collapse
|
26
|
Goldman S, Bron D, Tousseyn T, Vierasu I, Dewispelaere L, Heimann P, Cogan E, Goldman M. Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report. Front Med (Lausanne) 2021; 8:798095. [PMID: 34901098 PMCID: PMC8656165 DOI: 10.3389/fmed.2021.798095] [Citation(s) in RCA: 26] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Accepted: 11/08/2021] [Indexed: 01/11/2023] Open
Abstract
Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after administration of a BNT162b2 mRNA vaccine booster in a man recently diagnosed with AITL.
Collapse
Affiliation(s)
- Serge Goldman
- Department of Nuclear Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
| | - Dominique Bron
- Department of Hematology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium
| | - Thomas Tousseyn
- Department of Pathology, UZ Leuven Hospitals, Leuven, Belgium
| | - Irina Vierasu
- Department of Nuclear Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
| | - Laurent Dewispelaere
- Laboratory of Hematology, LHUB, Université Libre de Bruxelles, Brussels, Belgium
| | - Pierre Heimann
- Laboratory of Hematology, LHUB, Université Libre de Bruxelles, Brussels, Belgium
| | - Elie Cogan
- Department of Internal Medicine, CHIREC Hospital, Brussels, Belgium
| | - Michel Goldman
- I3h Institute, Université Libre de Bruxelles, Brussels, Belgium
| |
Collapse
|
27
|
Frappaz D, Dhall G, Murray MJ, Goldman S, Faure Conter C, Allen J, Kortmann R, Haas-Kogen D, Morana G, Finlay J, Nicholson JC, Bartels U, Souweidane M, Schöenberger S, Vasiljevic A, Robertson P, Albanese A, Alapetite C, Czech T, Lau CC, Wen P, Schiff D, Shaw D, Calaminus G, Bouffet E. Intracranial germ cell tumors in Adolescents and Young Adults: European and North American consensus review, current management and future development. Neuro Oncol 2021; 24:516-527. [PMID: 34724065 PMCID: PMC8972311 DOI: 10.1093/neuonc/noab252] [Citation(s) in RCA: 52] [Impact Index Per Article: 17.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The incidence of intracranial germ cell tumors (iGCT) is much lower in European and North American (E&NA) than in Asian population. However, E&NA cooperative groups have simultaneously developed with success treatment strategies with specific attention paid to long-term sequelae. Neurological sequelae may be reduced by establishing a diagnosis with an endoscopic biopsy and/or cerebrospinal fluid (CSF) and/or serum analysis, deferring the need to perform a radical surgery. Depending on markers and/or histological characteristics, patients are treated as either germinoma or non-germinomatous germ cell tumors (NGGCT). Metastatic disease is defined by a positive CSF cytology and/or distant drops in craniospinal MRI. The combination of surgery and/or chemotherapy and radiation therapy is tailored according to grouping and staging. With more than 90% 5-year event-free survival (EFS), localized germinomas can be managed without aggressive surgery, and benefit from chemotherapy followed by whole ventricular irradiation with local boost. Bifocal germinomas are treated as non-metastatic entities. Metastatic germinomas may be cured with craniospinal irradiation. With a 5-year EFS over 70%, NGGCT benefit from chemotherapy followed by delayed surgery in case of residual disease, and some form of radiotherapy. Future strategies will aim at decreasing long-term side effects while preserving high cure rates.
Collapse
Affiliation(s)
- D Frappaz
- Institut d'Hématologie Oncologie Pédiatrique, Lyon, France
| | - G Dhall
- University of Alabama at Birmingham (UAB), Birmingham, USA
| | - M J Murray
- Department of Pathology, University of Cambridge, Cambridge, UK.,Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - S Goldman
- Phoenix Children's Hospital University of Arizona, USA
| | - C Faure Conter
- Institut d'Hématologie Oncologie Pédiatrique, Lyon, France
| | - J Allen
- NYU Grossman School, New York, USA
| | - R Kortmann
- University of Leipzig Medical Center; Leipzig, Germany
| | | | | | - J Finlay
- Nationwide Children's Hospital, Colombus, USA
| | - J C Nicholson
- Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Ute Bartels
- The Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - M Souweidane
- Memorial Sloan Kettering Cancer Center, New York, USA
| | - S Schöenberger
- Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany
| | - A Vasiljevic
- Centre de Pathologie et Neuropathologie Est, Hospices Civils de Lyon, France
| | | | | | | | - T Czech
- Medical University of Vienna, Austria
| | - C C Lau
- Connecticut Children's Medical Center, USA
| | - P Wen
- University of Leipzig Medical Center; Leipzig, Germany
| | - D Schiff
- University of Virginia School of Medicine, Charlottesville, USA
| | - D Shaw
- Seattle Children's Hospital and University of Washington, Seattle USA
| | | | - E Bouffet
- The Hospital for Sick Children, University of Toronto, Toronto, Canada
| |
Collapse
|
28
|
Martens C, Lebrun L, Decaestecker C, Vandamme T, Van Eycke YR, Rovai A, Metens T, Debeir O, Goldman S, Salmon I, Van Simaeys G. Initial Condition Assessment for Reaction-Diffusion Glioma Growth Models: A Translational MRI-Histology (In)Validation Study. Tomography 2021; 7:650-674. [PMID: 34842805 PMCID: PMC8628987 DOI: 10.3390/tomography7040055] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2021] [Revised: 10/22/2021] [Accepted: 10/25/2021] [Indexed: 01/21/2023] Open
Abstract
Reaction-diffusion models have been proposed for decades to capture the growth of gliomas. Nevertheless, these models require an initial condition: the tumor cell density distribution over the whole brain at diagnosis time. Several works have proposed to relate this distribution to abnormalities visible on magnetic resonance imaging (MRI). In this work, we verify these hypotheses by stereotactic histological analysis of a non-operated brain with glioblastoma using a 3D-printed slicer. Cell density maps are computed from histological slides using a deep learning approach. The density maps are then registered to a postmortem MR image and related to an MR-derived geodesic distance map to the tumor core. The relation between the edema outlines visible on T2-FLAIR MRI and the distance to the core is also investigated. Our results suggest that (i) the previously proposed exponential decrease of the tumor cell density with the distance to the core is reasonable but (ii) the edema outlines would not correspond to a cell density iso-contour and (iii) the suggested tumor cell density at these outlines is likely overestimated. These findings highlight the limitations of conventional MRI to derive glioma cell density maps and the need for other initialization methods for reaction-diffusion models to be used in clinical practice.
Collapse
Affiliation(s)
- Corentin Martens
- Department of Nuclear Medicine, Hôpital Erasme, Université Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (A.R.); (S.G.); (G.V.S.)
- Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (C.D.); (Y.-R.V.E.); (O.D.); (I.S.)
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université Libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (T.V.); (T.M.)
| | - Laetitia Lebrun
- Department of Pathology, Hôpital Erasme, Université Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium;
| | - Christine Decaestecker
- Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (C.D.); (Y.-R.V.E.); (O.D.); (I.S.)
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université Libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (T.V.); (T.M.)
| | - Thomas Vandamme
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université Libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (T.V.); (T.M.)
| | - Yves-Rémi Van Eycke
- Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (C.D.); (Y.-R.V.E.); (O.D.); (I.S.)
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université Libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (T.V.); (T.M.)
| | - Antonin Rovai
- Department of Nuclear Medicine, Hôpital Erasme, Université Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (A.R.); (S.G.); (G.V.S.)
| | - Thierry Metens
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université Libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (T.V.); (T.M.)
- Department of Radiology, Hôpital Erasme, Université Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium
| | - Olivier Debeir
- Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (C.D.); (Y.-R.V.E.); (O.D.); (I.S.)
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université Libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (T.V.); (T.M.)
| | - Serge Goldman
- Department of Nuclear Medicine, Hôpital Erasme, Université Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (A.R.); (S.G.); (G.V.S.)
- Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (C.D.); (Y.-R.V.E.); (O.D.); (I.S.)
| | - Isabelle Salmon
- Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (C.D.); (Y.-R.V.E.); (O.D.); (I.S.)
- Department of Pathology, Hôpital Erasme, Université Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium;
| | - Gaetan Van Simaeys
- Department of Nuclear Medicine, Hôpital Erasme, Université Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (A.R.); (S.G.); (G.V.S.)
- Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, Rue Adrienne Bolland 8, 6041 Charleroi, Belgium; (C.D.); (Y.-R.V.E.); (O.D.); (I.S.)
| |
Collapse
|
29
|
Van Bogaert C, Mathey C, Vierasu I, Trotta N, Rocq L, Wolfromm A, De Wilde V, Goldman S. Painful ophthalmoplegia in a patient with a history of marginal zone lymphoma. Eur J Hybrid Imaging 2021; 5:18. [PMID: 34617167 PMCID: PMC8494508 DOI: 10.1186/s41824-021-00113-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2021] [Accepted: 09/22/2021] [Indexed: 11/10/2022] Open
Abstract
A 73-year-old man with a history of marginal zone lymphoma was admitted to the emergency room for diplopia and ipsilateral headache. The Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) demonstrated intense and symmetrical hypermetabolism of the cavernous sinuses, and hypermetabolic lesions diffusely in the lymph nodes and bones. The diagnosis of high-grade relapse of lymphomatous disease was made. In this context, the homogenous and symmetric lesion of the cavernous sinuses, without any other encephalic or meningeal lesions, raised the hypothesis of a paraneoplastic origin. A plausible paraneoplastic link between the neuro-ophthalmological lesion and the malignant disorder is IgG4-related disease, a condition that may be associated with lymphoma. As in our case, this diagnosis is often presumptive because histopathological confirmation is difficult to obtain.
Collapse
Affiliation(s)
- C Van Bogaert
- Department of Nuclear Medicine, CUB-Hôpital Erasme, Anderlecht, Belgium.
| | - C Mathey
- Department of Nuclear Medicine, CUB-Hôpital Erasme, Anderlecht, Belgium
| | - I Vierasu
- Department of Nuclear Medicine, CUB-Hôpital Erasme, Anderlecht, Belgium
| | - N Trotta
- Department of Nuclear Medicine, CUB-Hôpital Erasme, Anderlecht, Belgium
| | - L Rocq
- Department of anatomopatholgy, CUB-Hôpital Erasme, Anderlecht, Belgium
| | - A Wolfromm
- Department of haematology, CUB-Hôpital Erasme, Anderlecht, Belgium
| | - V De Wilde
- Department of haematology, CUB-Hôpital Erasme, Anderlecht, Belgium
| | - S Goldman
- Department of Nuclear Medicine, CUB-Hôpital Erasme, Anderlecht, Belgium
| |
Collapse
|
30
|
Vander Ghinst M, Bourguignon M, Wens V, Naeije G, Ducène C, Niesen M, Hassid S, Choufani G, Goldman S, De Tiège X. Inaccurate cortical tracking of speech in adults with impaired speech perception in noise. Brain Commun 2021; 3:fcab186. [PMID: 34541530 PMCID: PMC8445395 DOI: 10.1093/braincomms/fcab186] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2021] [Revised: 06/05/2021] [Accepted: 06/08/2021] [Indexed: 01/17/2023] Open
Abstract
Impaired speech perception in noise despite normal peripheral auditory function is a common problem in young adults. Despite a growing body of research, the pathophysiology of this impairment remains unknown. This magnetoencephalography study characterizes the cortical tracking of speech in a multi-talker background in a group of highly selected adult subjects with impaired speech perception in noise without peripheral auditory dysfunction. Magnetoencephalographic signals were recorded from 13 subjects with impaired speech perception in noise (six females, mean age: 30 years) and matched healthy subjects while they were listening to 5 different recordings of stories merged with a multi-talker background at different signal to noise ratios (No Noise, +10, +5, 0 and −5 dB). The cortical tracking of speech was quantified with coherence between magnetoencephalographic signals and the temporal envelope of (i) the global auditory scene (i.e. the attended speech stream and the multi-talker background noise), (ii) the attended speech stream only and (iii) the multi-talker background noise. Functional connectivity was then estimated between brain areas showing altered cortical tracking of speech in noise in subjects with impaired speech perception in noise and the rest of the brain. All participants demonstrated a selective cortical representation of the attended speech stream in noisy conditions, but subjects with impaired speech perception in noise displayed reduced cortical tracking of speech at the syllable rate (i.e. 4–8 Hz) in all noisy conditions. Increased functional connectivity was observed in subjects with impaired speech perception in noise in Noiseless and speech in noise conditions between supratemporal auditory cortices and left-dominant brain areas involved in semantic and attention processes. The difficulty to understand speech in a multi-talker background in subjects with impaired speech perception in noise appears to be related to an inaccurate auditory cortex tracking of speech at the syllable rate. The increased functional connectivity between supratemporal auditory cortices and language/attention-related neocortical areas probably aims at supporting speech perception and subsequent recognition in adverse auditory scenes. Overall, this study argues for a central origin of impaired speech perception in noise in the absence of any peripheral auditory dysfunction.
Collapse
Affiliation(s)
- Marc Vander Ghinst
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.,Service, d'ORL et de chirurgie cervico-faciale, CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium
| | - Mathieu Bourguignon
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.,Laboratory of Neurophysiology and Movement Biomechanics, UNI-ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.,Basque Center on Cognition, Brain and Language (BCBL), Donostia/San Sebastian 20009, Spain
| | - Vincent Wens
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.,Clinics of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium
| | - Gilles Naeije
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.,Service de Neurologie, ULB-Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels 1070, Belgium
| | - Cecile Ducène
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.,Service, d'ORL et de chirurgie cervico-faciale, CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium
| | - Maxime Niesen
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.,Service, d'ORL et de chirurgie cervico-faciale, CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium
| | - Sergio Hassid
- Service, d'ORL et de chirurgie cervico-faciale, CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium
| | - Georges Choufani
- Service, d'ORL et de chirurgie cervico-faciale, CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium
| | - Serge Goldman
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.,Clinics of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium
| | - Xavier De Tiège
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.,Clinics of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium
| |
Collapse
|
31
|
Naeije G, Coquelet N, Wens V, Goldman S, Pandolfo M, De Tiège X. Age of onset modulates resting-state brain network dynamics in Friedreich Ataxia. Hum Brain Mapp 2021; 42:5334-5344. [PMID: 34523778 PMCID: PMC8519851 DOI: 10.1002/hbm.25621] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2021] [Revised: 07/19/2021] [Accepted: 07/20/2021] [Indexed: 02/06/2023] Open
Abstract
This magnetoencephalography (MEG) study addresses (i) how Friedreich ataxia (FRDA) affects the sub‐second dynamics of resting‐state brain networks, (ii) the main determinants of their dynamic alterations, and (iii) how these alterations are linked with FRDA‐related changes in resting‐state functional brain connectivity (rsFC) over long timescales. For that purpose, 5 min of resting‐state MEG activity were recorded in 16 FRDA patients (mean age: 27 years, range: 12–51 years; 10 females) and matched healthy subjects. Transient brain network dynamics was assessed using hidden Markov modeling (HMM). Post hoc median‐split, nonparametric permutations and Spearman rank correlations were used for statistics. In FRDA patients, a positive correlation was found between the age of symptoms onset (ASO) and the temporal dynamics of two HMM states involving the posterior default mode network (DMN) and the temporo‐parietal junctions (TPJ). FRDA patients with an ASO <11 years presented altered temporal dynamics of those two HMM states compared with FRDA patients with an ASO > 11 years or healthy subjects. The temporal dynamics of the DMN state also correlated with minute‐long DMN rsFC. This study demonstrates that ASO is the main determinant of alterations in the sub‐second dynamics of posterior associative neocortices in FRDA patients and substantiates a direct link between sub‐second network activity and functional brain integration over long timescales.
Collapse
Affiliation(s)
- Gilles Naeije
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Neurology, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Nicolas Coquelet
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Vincent Wens
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Serge Goldman
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Functional Neuroimaging, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Massimo Pandolfo
- Department of Neurology and Neurosurgery, McGill University, Montreal, Canada
| | - Xavier De Tiège
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Functional Neuroimaging, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| |
Collapse
|
32
|
Mathey C, Keyzer C, Blocklet D, Van Simaeys G, Trotta N, Lacroix S, Corvilain B, Goldman S, Moreno-Reyes R. 18F-fluorocholine PET/CT is more sensitive than 11C-methionine PET/CT for the localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism. J Nucl Med 2021; 63:785-791. [PMID: 34413141 DOI: 10.2967/jnumed.121.262395] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Revised: 08/05/2021] [Indexed: 11/16/2022] Open
Abstract
Purpose: Preoperative molecular imaging is paramount to direct surgery in primary hyperparathyroidism (pHTP). We investigate the diagnostic performance of 18F-fluorocholine (18F-FCH) PET/CT compared to 11C-methionine (11C-MET) PET/CT for the localization of hyperfunctioning parathyroid tissue in patients with pHTP and negative or inconclusive 99mTc-sestaMIBI SPECT (MIBI) findings. Materials and Methods: Fifty-eight patients with biochemical evidence of pHTP and negative or inconclusive MIBI were referred for pre-surgical detection and localization of hyperfunctioning parathyroid tissue by 11C-MET- and 18F-FCH-PET/CT. The PET/CT results were classified into 3 categories (positive, inconclusive or negative) based on the nodular aspect of tracer uptake and the visualisation of corresponding nodules on CT. The PET/CT results were correlated with the surgical and histopathological findings used as gold standard. Results: Fifty-three patients were included for analysis. 18F-FCH-PET/CT was positive in 39 patients (74%), inconclusive in 5 (9%) and negative in 9 (17%), compared to 25 (47%), 12 (23%) and 16 (30%) respectively for 11C-MET-PET/CT. 18F-FCH localized 11 additional foci (6 positive and 5 inconclusive) compared to 11C-MET. Twenty-six patients (sex F/M ratio16/10) underwent surgery with resection of 31 lesions (22 adenomas, 6 hyperplastic glands, 3 carcinomas) and 1 normal gland. At follow-up, twenty-one (81%) patients were considered cured after surgery, while 3 (12%) patients had persistence of hypercalcaemia. With inconclusive cases being considered as negative, 18F-FCH-PET/CT correctly localized 26 lesions in 24/26 (92%) patients compared to 16 lesions in 15/26 (58%) patients localized by 11C-MET-PET/CT. Per patient-based sensitivity and positive predictive value (PPV) were 96% and 96% for 18F-FCH and 60% and 94% for 11C-MET (p<0.0001). Per lesion-based sensitivity and PPV were respectively 84% and 90% for 18F-FCH vs. 52% and 94% for 11C-MET (p<0.0001). Conclusion: In the presence of biochemical evidence of pHTP with negative or inconclusive MIBI, 18F-FCH-PET/CT has a better performance than 11C-MET-PET/CT for the detection of pathological parathyroid tissue, allowing localization of parathyroid adenoma or hyperplasia in 96% of patients.
Collapse
|
33
|
Puttaert D, Wens V, Fery P, Rovai A, Trotta N, Coquelet N, De Breucker S, Sadeghi N, Coolen T, Goldman S, Peigneux P, Bier JC, De Tiège X. Decreased Alpha Peak Frequency Is Linked to Episodic Memory Impairment in Pathological Aging. Front Aging Neurosci 2021; 13:711375. [PMID: 34475819 PMCID: PMC8406997 DOI: 10.3389/fnagi.2021.711375] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2021] [Accepted: 07/21/2021] [Indexed: 12/04/2022] Open
Abstract
The Free and Cued Selective Reminding Test (FCSRT) is a largely validated neuropsychological test for the identification of amnestic syndrome from the early stage of Alzheimer's disease (AD). Previous electrophysiological data suggested a slowing down of the alpha rhythm in the AD-continuum as well as a key role of this rhythmic brain activity for episodic memory processes. This study therefore investigates the link between alpha brain activity and alterations in episodic memory as assessed by the FCSRT. For that purpose, 37 patients with altered FCSRT performance underwent a comprehensive neuropsychological assessment, supplemented by 18F-fluorodeoxyglucose positron emission tomography/structural magnetic resonance imaging (18FDG-PET/MR), and 10 min of resting-state magnetoencephalography (MEG). The individual alpha peak frequency (APF) in MEG resting-state data was positively correlated with patients' encoding efficiency as well as with the efficacy of semantic cues in facilitating patients' retrieval of previous stored word. The APF also correlated positively with patients' hippocampal volume and their regional glucose consumption in the posterior cingulate cortex. Overall, this study demonstrates that alterations in the ability to learn and store new information for a relatively short-term period are related to a slowing down of alpha rhythmic activity, possibly due to altered interactions in the extended mnemonic system. As such, a decreased APF may be considered as an electrophysiological correlate of short-term episodic memory dysfunction accompanying pathological aging.
Collapse
Affiliation(s)
- Delphine Puttaert
- Laboratoire de Cartographie Fonctionnelle du Cerveau, ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium
- Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences, ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium
| | - Vincent Wens
- Laboratoire de Cartographie Fonctionnelle du Cerveau, ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium
- Clinic of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Patrick Fery
- Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences, ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium
- Service of Neuropsychology and Speech Therapy, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Antonin Rovai
- Laboratoire de Cartographie Fonctionnelle du Cerveau, ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium
- Clinic of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Nicola Trotta
- Laboratoire de Cartographie Fonctionnelle du Cerveau, ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium
- Clinic of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Nicolas Coquelet
- Laboratoire de Cartographie Fonctionnelle du Cerveau, ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium
| | - Sandra De Breucker
- Department of Geriatrics, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Niloufar Sadeghi
- Department of Radiology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Tim Coolen
- Department of Radiology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Serge Goldman
- Laboratoire de Cartographie Fonctionnelle du Cerveau, ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium
- Clinic of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Philippe Peigneux
- Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences, ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium
| | - Jean-Christophe Bier
- Department of Neurology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Xavier De Tiège
- Laboratoire de Cartographie Fonctionnelle du Cerveau, ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium
- Clinic of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| |
Collapse
|
34
|
Van Dyck D, Deconinck N, Aeby A, Baijot S, Coquelet N, Trotta N, Rovai A, Goldman S, Urbain C, Wens V, De Tiège X. Resting-state functional brain connectivity is related to subsequent procedural learning skills in school-aged children. Neuroimage 2021; 240:118368. [PMID: 34242786 DOI: 10.1016/j.neuroimage.2021.118368] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2021] [Revised: 06/30/2021] [Accepted: 07/05/2021] [Indexed: 10/20/2022] Open
Abstract
This magnetoencephalography (MEG) study investigates how procedural sequence learning performance is related to prior brain resting-state functional connectivity (rsFC), and to what extent sequence learning induces rapid changes in brain rsFC in school-aged children. Procedural learning was assessed in 30 typically developing children (mean age ± SD: 9.99 years ± 1.35) using a serial reaction time task (SRTT). During SRTT, participants touched as quickly and accurately as possible a stimulus sequentially or randomly appearing in one of the quadrants of a touchscreen. Band-limited power envelope correlation (brain rsFC) was applied to MEG data acquired at rest pre- and post-learning. Correlation analyses were performed between brain rsFC and sequence-specific learning or response time indices. Stronger pre-learning interhemispheric rsFC between inferior parietal and primary somatosensory/motor areas correlated with better subsequent sequence learning performance and faster visuomotor response time. Faster response time was associated with post-learning decreased rsFC within the dorsal extra-striate visual stream and increased rsFC between temporo-cerebellar regions. In school-aged children, variations in functional brain architecture at rest within the sensorimotor network account for interindividual differences in sequence learning and visuomotor performance. After learning, rapid adjustments in functional brain architecture are associated with visuomotor performance but not sequence learning skills.
Collapse
Affiliation(s)
- Dorine Van Dyck
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université libre de Bruxelles (ULB), Brussels, Belgium.
| | - Nicolas Deconinck
- Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Alec Aeby
- Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université libre de Bruxelles (ULB), Brussels, Belgium; Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences (CRCN) and ULB Neurosciences Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Simon Baijot
- Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université libre de Bruxelles (ULB), Brussels, Belgium; Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences (CRCN) and ULB Neurosciences Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Nicolas Coquelet
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Nicola Trotta
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Antonin Rovai
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Serge Goldman
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Charline Urbain
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences (CRCN) and ULB Neurosciences Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Vincent Wens
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Xavier De Tiège
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium; Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| |
Collapse
|
35
|
Niesen M, Trotta N, Noel A, Coolen T, Fayad G, Leurkin-Sterk G, Delpierre I, Henrard S, Sadeghi N, Goffard JC, Goldman S, De Tiège X. Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell. Eur J Nucl Med Mol Imaging 2021; 48:1890-1901. [PMID: 33398411 PMCID: PMC7781559 DOI: 10.1007/s00259-020-05154-6] [Citation(s) in RCA: 26] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2020] [Accepted: 12/06/2020] [Indexed: 12/25/2022]
Abstract
OBJECTIVES Sudden loss of smell is a very common symptom of coronavirus disease 19 (COVID-19). This study characterizes the structural and metabolic cerebral correlates of dysosmia in patients with COVID-19. METHODS Structural brain magnetic resonance imaging (MRI) and positron emission tomography with [18F]-fluorodeoxyglucose (FDG-PET) were prospectively acquired simultaneously on a hybrid PET-MR in 12 patients (2 males, 10 females, mean age: 42.6 years, age range: 23-60 years) with sudden dysosmia and positive detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on nasopharyngeal swab specimens. FDG-PET data were analyzed using a voxel-based approach and compared with that of a group of healthy subjects. RESULTS Bilateral blocking of the olfactory cleft was observed in six patients, while subtle olfactory bulb asymmetry was found in three patients. No MRI signal abnormality downstream of the olfactory tract was observed. Decrease or increase in glucose metabolism abnormalities was observed (p < .001 uncorrected, k ≥ 50 voxels) in core olfactory and high-order neocortical areas. A modulation of regional cerebral glucose metabolism by the severity and the duration of COVID-19-related dysosmia was disclosed using correlation analyses. CONCLUSIONS This PET-MR study suggests that sudden loss of smell in COVID-19 is not related to central involvement due to SARS-CoV-2 neuroinvasiveness. Loss of smell is associated with subtle cerebral metabolic changes in core olfactory and high-order cortical areas likely related to combined processes of deafferentation and active functional reorganization secondary to the lack of olfactory stimulation.
Collapse
Affiliation(s)
- Maxime Niesen
- Department of Otorhinolaryngology, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium.
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI - ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.
| | - Nicola Trotta
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI - ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
- Department of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Antoine Noel
- Department of Otorhinolaryngology, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Tim Coolen
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI - ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
- Department of Radiology, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Georges Fayad
- Department of Otorhinolaryngology, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Gil Leurkin-Sterk
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI - ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
- Department of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Isabelle Delpierre
- Department of Radiology, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Sophie Henrard
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI - ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
- Department of Internal Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Niloufar Sadeghi
- Department of Radiology, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Jean-Christophe Goffard
- Department of Internal Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Serge Goldman
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI - ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
- Department of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Xavier De Tiège
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI - ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
- Department of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| |
Collapse
|
36
|
Martens C, Debeir O, Decaestecker C, Metens T, Lebrun L, Leurquin-Sterk G, Trotta N, Goldman S, Van Simaeys G. Voxelwise Principal Component Analysis of Dynamic [S-Methyl- 11C]Methionine PET Data in Glioma Patients. Cancers (Basel) 2021; 13:cancers13102342. [PMID: 34066294 PMCID: PMC8152079 DOI: 10.3390/cancers13102342] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 04/30/2021] [Accepted: 05/09/2021] [Indexed: 01/08/2023] Open
Abstract
Recent works have demonstrated the added value of dynamic amino acid positron emission tomography (PET) for glioma grading and genotyping, biopsy targeting, and recurrence diagnosis. However, most of these studies are based on hand-crafted qualitative or semi-quantitative features extracted from the mean time activity curve within predefined volumes. Voxelwise dynamic PET data analysis could instead provide a better insight into intra-tumor heterogeneity of gliomas. In this work, we investigate the ability of principal component analysis (PCA) to extract relevant quantitative features from a large number of motion-corrected [S-methyl-11C]methionine ([11C]MET) PET frames. We first demonstrate the robustness of our methodology to noise by means of numerical simulations. We then build a PCA model from dynamic [11C]MET acquisitions of 20 glioma patients. In a distinct cohort of 13 glioma patients, we compare the parametric maps derived from our PCA model to these provided by the classical one-compartment pharmacokinetic model (1TCM). We show that our PCA model outperforms the 1TCM to distinguish characteristic dynamic uptake behaviors within the tumor while being less computationally expensive and not requiring arterial sampling. Such methodology could be valuable to assess the tumor aggressiveness locally with applications for treatment planning and response evaluation. This work further supports the added value of dynamic over static [11C]MET PET in gliomas.
Collapse
Affiliation(s)
- Corentin Martens
- Department of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (G.L.-S.); (N.T.); (S.G.); (G.V.S.)
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (O.D.); (C.D.); (T.M.)
- Correspondence:
| | - Olivier Debeir
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (O.D.); (C.D.); (T.M.)
| | - Christine Decaestecker
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (O.D.); (C.D.); (T.M.)
| | - Thierry Metens
- Laboratory of Image Synthesis and Analysis (LISA), École Polytechnique de Bruxelles, Université libre de Bruxelles, Avenue Franklin Roosevelt 50, 1050 Brussels, Belgium; (O.D.); (C.D.); (T.M.)
- Department of Radiology, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium
| | - Laetitia Lebrun
- Department of Pathology, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium;
| | - Gil Leurquin-Sterk
- Department of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (G.L.-S.); (N.T.); (S.G.); (G.V.S.)
| | - Nicola Trotta
- Department of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (G.L.-S.); (N.T.); (S.G.); (G.V.S.)
| | - Serge Goldman
- Department of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (G.L.-S.); (N.T.); (S.G.); (G.V.S.)
| | - Gaetan Van Simaeys
- Department of Nuclear Medicine, Hôpital Erasme, Université libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium; (G.L.-S.); (N.T.); (S.G.); (G.V.S.)
| |
Collapse
|
37
|
Costers L, Van Schependom J, Laton J, Baijot J, Sjøgård M, Wens V, De Tiège X, Goldman S, D'Haeseleer M, D'hooghe MB, Woolrich M, Nagels G. The role of hippocampal theta oscillations in working memory impairment in multiple sclerosis. Hum Brain Mapp 2021; 42:1376-1390. [PMID: 33247542 PMCID: PMC7927306 DOI: 10.1002/hbm.25299] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2020] [Revised: 11/11/2020] [Accepted: 11/13/2020] [Indexed: 01/04/2023] Open
Abstract
Working memory (WM) problems are frequently present in people with multiple sclerosis (MS). Even though hippocampal damage has been repeatedly shown to play an important role, the underlying neurophysiological mechanisms remain unclear. This study aimed to investigate the neurophysiological underpinnings of WM impairment in MS using magnetoencephalography (MEG) data from a visual-verbal 2-back task. We analysed MEG recordings of 79 MS patients and 38 healthy subjects through event-related fields and theta (4-8 Hz) and alpha (8-13 Hz) oscillatory processes. Data was source reconstructed and parcellated based on previous findings in the healthy subject sample. MS patients showed a smaller maximum theta power increase in the right hippocampus between 0 and 400 ms than healthy subjects (p = .014). This theta power increase value correlated negatively with reaction time on the task in MS (r = -.32, p = .029). Evidence was provided that this relationship could not be explained by a 'common cause' confounding relationship with MS-related neuronal damage. This study provides the first neurophysiological evidence of the influence of hippocampal dysfunction on WM performance in MS.
Collapse
Affiliation(s)
- Lars Costers
- AIMS Lab, Center For NeurosciencesUZ Brussel, Vrije Universiteit BrusselBrusselBelgium
| | - Jeroen Van Schependom
- AIMS Lab, Center For NeurosciencesUZ Brussel, Vrije Universiteit BrusselBrusselBelgium
- Departement of Electronics and Informatics (ETRO)Vrije Universiteit BrusselBrusselBelgium
- Departement of RadiologyUZ BrusselBrusselBelgium
| | - Jorne Laton
- AIMS Lab, Center For NeurosciencesUZ Brussel, Vrije Universiteit BrusselBrusselBelgium
- Nuffield Department of Clinical NeurosciencesUniversity of OxfordOxfordUK
| | - Johan Baijot
- AIMS Lab, Center For NeurosciencesUZ Brussel, Vrije Universiteit BrusselBrusselBelgium
| | - Martin Sjøgård
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC)UNI—ULB Neuroscience Institute, Université libre de Bruxelles (ULB)BruxellesBelgium
| | - Vincent Wens
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC)UNI—ULB Neuroscience Institute, Université libre de Bruxelles (ULB)BruxellesBelgium
- Magnetoencephalography Unit, Department of Functional Neuroimaging, Service of Nuclear MedicineCUB‐Hôpital ErasmeBruxellesBelgium
| | - Xavier De Tiège
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC)UNI—ULB Neuroscience Institute, Université libre de Bruxelles (ULB)BruxellesBelgium
- Magnetoencephalography Unit, Department of Functional Neuroimaging, Service of Nuclear MedicineCUB‐Hôpital ErasmeBruxellesBelgium
| | - Serge Goldman
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC)UNI—ULB Neuroscience Institute, Université libre de Bruxelles (ULB)BruxellesBelgium
- Magnetoencephalography Unit, Department of Functional Neuroimaging, Service of Nuclear MedicineCUB‐Hôpital ErasmeBruxellesBelgium
| | - Miguel D'Haeseleer
- Department of NeurologyNational MS Center MelsbroekMelsbroekBelgium
- Department of NeurologyUZ BrusselsBruxellesBelgium
| | - Marie Beatrice D'hooghe
- Department of NeurologyNational MS Center MelsbroekMelsbroekBelgium
- Department of NeurologyUZ BrusselsBruxellesBelgium
| | - Mark Woolrich
- Oxford Centre for Human Brain Activity (OHBA)University of OxfordOxfordUK
- Oxford University Centre for Functional MRI of the Brain (FMRIB)University of OxfordOxfordUK
| | - Guy Nagels
- AIMS Lab, Center For NeurosciencesUZ Brussel, Vrije Universiteit BrusselBrusselBelgium
- Department of NeurologyUZ BrusselsBruxellesBelgium
- St Edmund HallUniversity of OxfordOxfordUK
| |
Collapse
|
38
|
Bohlok A, Duran Derijckere I, Azema H, Lucidi V, Vankerckhove S, Hendlisz A, Van Laethem JL, Vierasu I, Goldman S, Flamen P, Larsimont D, Demetter P, Dirix L, Vermeulen P, Donckier V. Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases. J Surg Oncol 2021; 123:1773-1783. [PMID: 33751583 PMCID: PMC8251827 DOI: 10.1002/jso.26466] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2021] [Revised: 02/23/2021] [Accepted: 03/08/2021] [Indexed: 12/17/2022]
Abstract
BACKGROUND AND OBJECTIVES The histological growth pattern (HGP) represents a strong prognostic factor in patients undergoing surgery for colorectal liver metastases (CRLM). We evaluated whether the combination of HGP with clinico-metabolic parameters could improve its prognostic value. METHODS In a series of 108 patients undergoing resection of CRLM, the HGP of CRLM was scored according to international guidelines. Baseline clinico-metabolic clinical status was evaluated using a metabolic-Clinical Risk Score (mCRS), combining traditional Memorial Sloan Kettering-CRS parameters with the tumor-to-liver glucose uptake ratio as measured with 18 Fluorodeoxyglucose/positron emission tomography. RESULTS In patients with desmoplastic HGP (DHGP) CRLM (20% of all patients), 5- and 10-years overall survival (OS) and disease free survival (DFS) were 66% and 43% and 37% and 24.5%, as compared with 35% and 21% and 11% and 11% in the non-DHGP group (p = 0.07 and 0.054). Among DHGP patients, those with a low-risk mCRS had improved postoperative outcomes, 5- and 10-years OS and DFS reaching 83.3% and 62.5% and 50% and 33%, as compared with 18% and 0% and 0% and 0% in high-risk mCRS patients (p = 0.007 and 0.003). In contrast, mCRS did not influence postoperative survivals in non-DHGP patients. CONCLUSIONS Combining the clinico-metabolic characteristics with the HGP may improve prognostication in patients undergoing surgery for CRLM.
Collapse
Affiliation(s)
- Ali Bohlok
- Department of Surgical Oncology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium
| | - Ivan Duran Derijckere
- Department of Nuclear Medicine, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium
| | - Hugues Azema
- Department of Surgical Oncology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium
| | - Valerio Lucidi
- Department of Abdominal Surgery, Erasme Hospital, Free University of Brussels (ULB), Brussels, Belgium
| | - Sophie Vankerckhove
- Department of Surgical Oncology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium
| | - Alain Hendlisz
- Department of Digestive Oncology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium
| | - Jean Luc Van Laethem
- Department of Hepato-Gastroenterology, Erasme Hospital, Free University of Brussels (ULB), Brussels, Belgium
| | - Irina Vierasu
- Department of Nuclear Medicine, Erasme Hospital, Free University of Brussels (ULB), Brussels, Belgium
| | - Serge Goldman
- Department of Nuclear Medicine, Erasme Hospital, Free University of Brussels (ULB), Brussels, Belgium
| | - Patrick Flamen
- Department of Nuclear Medicine, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium
| | - Denis Larsimont
- Department of Pathology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium
| | - Pieter Demetter
- Department of Pathology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium
| | - Luc Dirix
- Translational Cancer Research Unit (CORE), Gasthuiszusters Antwerpen Hospitals, University of Antwerp, Antwerp, Belgium
| | - Peter Vermeulen
- Translational Cancer Research Unit, GZA Hospitals & CORE, MIPRO, University of Antwerp, Antwerp, Belgium
| | - Vincent Donckier
- Department of Surgical Oncology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium
| |
Collapse
|
39
|
Weiss A, Baram S, Geslevich Y, Goldman S, Nothman S, Beck-Fruchter R. Should the modified natural cycle protocol for frozen embryo transfer be modified? A prospective case series proof of concept study. Eur J Obstet Gynecol Reprod Biol 2021; 258:179-183. [PMID: 33444812 DOI: 10.1016/j.ejogrb.2021.01.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2020] [Revised: 11/18/2020] [Accepted: 01/04/2021] [Indexed: 11/27/2022]
Abstract
OBJECTIVE Modified natural cycles for frozen embryo transfer utilize an ovulation trigger which assists in embryo transfer scheduling and simplifies cycle monitoring. There have been conflicting results with this protocol and modifications may be sought. We wanted to ascertain whether a modified natural protocol for frozen embryo transfer without triggered ovulation but with luteal progesterone support disconnecting the timing of embryo transfer from the timing of the LH surge can achieve a high pregnancy rate. STUDY DESIGN Candidates for frozen embryo transfer of 48-h cleavage cell embryos were recruited from May 2016 to April 2018. The patients were monitored for endometrial growth, follicle formation and estradiol, progesterone, and LH hormone levels. After meeting the predetermined criteria, embryo transfer was scheduled. The patients began progesterone treatment 48 h before embryo transfer, regardless of identification of the LH surge if ovulation had not commenced. The predetermined primary outcome was the biochemical pregnancy rate while the secondary outcome included the clinical pregnancy rate and the ongoing pregnancy rate. Patients were monitored to the eighth week of pregnancy, but data was collected from the medical records to provide the live birth rate as well. RESULTS Fifty-six women were screened. Eleven women declined or did not meet the inclusion criteria. Three had anovulatory cycles and were excluded. Forty-two women were included in the statistical analysis. The implantation rate was 42.9 % [95 %CI 29.3 %-56.4 %). Of the 42 participants, 25 (59.5 %) conceived [95 % CI 44.0 %-75 %]. Two pregnancies ended in first trimester miscarriage leaving 23 (54.7 %) ongoing pregnancies [95 % CI 39.1 %-70.5 %]. One patient experienced a late abortion such that the live birth rate was 22 of 42 patients or 52.4 % [95 % CI 36.4 %-68.0 %]. CONCLUSION The proposed modified natural protocol which utilizes progesterone luteal support but does not trigger ovulation, maintains a high pregnancy rate while providing flexibility regarding the day of transfer disconnected from the day of the LH surge. This was a prospective, proof of concept study. This protocol may be suitable for smaller or public in-vitro fertility units whose resources are limited and facilities are not available daily. The high pregnancy and live birth rate that we found provides confidence that this protocol can be part of the armament of protocols the clinician may offer to his patients. Larger studies should confirm these findings.
Collapse
Affiliation(s)
- Amir Weiss
- Fertility Unit, Department of Obstetrics and Gynecology, Emek Medical Center, Afula, 1834111, Israel; Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, 3525433, Israel.
| | - S Baram
- Fertility Unit, Department of Obstetrics and Gynecology, Emek Medical Center, Afula, 1834111, Israel.
| | - Y Geslevich
- Fertility Unit, Department of Obstetrics and Gynecology, Emek Medical Center, Afula, 1834111, Israel.
| | - S Goldman
- Fertility Unit, Department of Obstetrics and Gynecology, Emek Medical Center, Afula, 1834111, Israel.
| | - S Nothman
- Fertility Unit, Department of Obstetrics and Gynecology, Emek Medical Center, Afula, 1834111, Israel; Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, 3525433, Israel.
| | - R Beck-Fruchter
- Fertility Unit, Department of Obstetrics and Gynecology, Emek Medical Center, Afula, 1834111, Israel.
| |
Collapse
|
40
|
Van Simaeys G, Doumont G, De Maeseneire C, Passon N, Lacroix S, Lentz C, Horion A, Warnier C, Torres D, Martens C, Vierasu I, Egrise D, Goldman S. [ 18F]-JK-PSMA-7 and [ 18F]-FDG tumour PET uptake in treated xenograft human prostate cancer model in mice. Eur J Nucl Med Mol Imaging 2021; 48:1773-1784. [PMID: 33398412 DOI: 10.1007/s00259-020-05169-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Accepted: 12/15/2020] [Indexed: 10/22/2022]
Abstract
PURPOSE This preclinical study aims to evaluate the extent to which a change in prostate-specific membrane antigen (PSMA) expression of castration-resistant prostate cancer (CRPC) following standard treatment is reflected in [18F]JK-PSMA-7 PET/CT. METHODS Castrated mice supplemented with testosterone implant were xenografted with human LNCaP CRPC. After appropriate tumour growth, androgen deprivation therapy (ADT) was carried out by the removal of the implant followed by a single injection of docetaxel (400 μg/20-g mouse) 2 weeks later. [18F]JK-PSMA-7 PET/CT were performed before ADT, then before and at days 12, 26, 47 and 69 after docetaxel administration. The [18F]JK-PSMA-7 PET data were compared to corresponding unspecific metabolic [18F]FDG PET/CT and ex vivo quantification of PSMA expression estimated by flow cytometry on repeated tumour biopsies. RESULTS ADT alone had no early effect on LNCaP tumours that pursued their progression. Until day 12 post-docetaxel, the [18F]JK-PSMA7 uptake was significantly higher than that of [18F]FDG, indicating the persistence of PSMA expression at those time points. From day 26 onwards when the tumours were rapidly expanding, both [18F]JK-PSMA7 and [18F]FDG uptake continuously decreased although the decrease in [18F]JK-PSMA uptake was markedly faster. The fraction of PSMA-positive cells in tumour biopsies decreased similarly over time to reach a non-specific level after the same time period. CONCLUSION Applying PSMA-based imaging for therapy monitoring in patients with CRPC should be considered with caution since a reduction in [18F]JK-PSMA-7 PET uptake after successive ADT and chemotherapy may be related to downregulation of PSMA expression in dedifferentiated and rapidly proliferating tumour cells.
Collapse
Affiliation(s)
- Gaetan Van Simaeys
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi, Belgium. .,Service de médecine nucléaire, Hôpital Érasme, Université libre de Bruxelles, Brussels, Belgium.
| | - Gilles Doumont
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi, Belgium
| | - Coraline De Maeseneire
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi, Belgium
| | - Nicolas Passon
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi, Belgium
| | - Simon Lacroix
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi, Belgium.,Service de médecine nucléaire, Hôpital Érasme, Université libre de Bruxelles, Brussels, Belgium
| | | | | | | | - David Torres
- Institute for Medical Immunology, Université libre de Bruxelles, Charleroi, Belgium
| | - Corentin Martens
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi, Belgium.,Service de médecine nucléaire, Hôpital Érasme, Université libre de Bruxelles, Brussels, Belgium
| | - Irina Vierasu
- Service de médecine nucléaire, Hôpital Érasme, Université libre de Bruxelles, Brussels, Belgium
| | - Dominique Egrise
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi, Belgium.,Service de médecine nucléaire, Hôpital Érasme, Université libre de Bruxelles, Brussels, Belgium
| | - Serge Goldman
- Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi, Belgium.,Service de médecine nucléaire, Hôpital Érasme, Université libre de Bruxelles, Brussels, Belgium
| |
Collapse
|
41
|
Scoppettuolo P, Ligot N, Remmelink M, Delpierre I, Goldman S, Naeije G, Vandergheynst F. Headache, Bilateral Carotid Stenosis, and Hypoglossal Palsy Revealing Granulomatosis with Polyangiitis: An Innovative Application of Vessel-Wall MRI. J Clin Neurol 2021; 17:137-139. [PMID: 33480211 PMCID: PMC7840331 DOI: 10.3988/jcn.2021.17.1.137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 09/01/2020] [Accepted: 09/01/2020] [Indexed: 11/25/2022] Open
Affiliation(s)
| | - Noémie Ligot
- Department of Neurology, Erasme Hospital, ULB, Brussels, Belgium
| | - Myriam Remmelink
- Department of Pathology, Erasme Hospital, ULB, Brussels, Belgium
| | | | - Serge Goldman
- Department of Nuclear Medicine, Erasme Hospital, ULB, Brussels, Belgium
| | - Gilles Naeije
- Department of Neurology, Erasme Hospital, ULB, Brussels, Belgium
| | | |
Collapse
|
42
|
Chiavarina B, Costanza B, Ronca R, Blomme A, Rezzola S, Chiodelli P, Giguelay A, Belthier G, Doumont G, Van Simaeys G, Lacroix S, Yokobori T, Erkhem-Ochir B, Balaguer P, Cavailles V, Fabbrizio E, Di Valentin E, Gofflot S, Detry O, Jerusalem G, Goldman S, Delvenne P, Bellahcène A, Pannequin J, Castronovo V, Turtoi A. Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis. Theranostics 2021; 11:1626-1640. [PMID: 33408771 PMCID: PMC7778592 DOI: 10.7150/thno.51507] [Citation(s) in RCA: 38] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2020] [Accepted: 11/04/2020] [Indexed: 12/22/2022] Open
Abstract
Colorectal cancer (CRC) cells are traditionally considered unresponsive to TGFβ due to mutations in the receptors and/or downstream signaling molecules. TGFβ influences CRC cells only indirectly via stromal cells, such as cancer-associated fibroblasts. However, CRC cell ability to directly respond to TGFβ currently remains unexplored. This represents a missed opportunity for diagnostic and therapeutic interventions. Methods: We examined whether cancer cells from primary CRC and liver metastases respond to TGFβ by inducing TGFβ-induced protein ig-h3 (TGFBI) expression, and the contribution of canonical and non-canonical TGFβ signaling pathways to this effect. We then investigated in vitro and in vivo TGFBI impact on metastasis formation and angiogenesis. Using patient serum samples and an orthotopic mouse model of CRC liver metastases we assessed the diagnostic/tumor targeting value of novel antibodies against TGFBI. Results: Metastatic CRC cells, such as circulating tumor cells, directly respond to TGFβ. These cells were characterized by the absence of TGFβ receptor mutations and the frequent presence of p53 mutations. The pro-tumorigenic program orchestrated by TGFβ in CRC cells was mediated through TGFBI, the expression of which was positively regulated by non-canonical TGFβ signaling cascades. TGFBI inhibition was sufficient to significantly reduce liver metastasis formation in vivo. Moreover, TGFBI pro-tumorigenic function was linked to its ability to stimulate angiogenesis. TGFBI levels were higher in serum samples from untreated patients with CRC than in patients who were receiving chemotherapy. A radiolabeled anti-TGFBI antibody selectively targeted metastatic lesions in vivo, underscoring its diagnostic and therapeutic potential. Conclusions: TGFβ signaling in CRC cells directly contributes to their metastatic potential and stromal cell-independence. Proteins downstream of activated TGFβ, such as TGFBI, represent novel diagnostic and therapeutic targets for more specific anti-metastatic therapies.
Collapse
Affiliation(s)
- Barbara Chiavarina
- Cancer Research Institute of Montpellier, Tumor Microenvironment and Resistance to Treatment Laboratory, INSERM U1194, Montpellier, France
- Institut National de la Santé et de la Recherche Médicale, Montpellier, France
- Institut du Cancer de Montpellier, Montpellier, France
- Université de Montpellier, Montpellier, France
| | - Brunella Costanza
- Metastasis Research Laboratory, GIGA Cancer, University of Liège, Liège, Belgium
| | - Roberto Ronca
- University of Brescia, Department of Molecular and Translational Medicine, Brescia, Italy
| | - Arnaud Blomme
- Metastasis Research Laboratory, GIGA Cancer, University of Liège, Liège, Belgium
| | - Sara Rezzola
- University of Brescia, Department of Molecular and Translational Medicine, Brescia, Italy
| | - Paola Chiodelli
- University of Brescia, Department of Molecular and Translational Medicine, Brescia, Italy
| | - Ambre Giguelay
- Cancer Research Institute of Montpellier, Tumor Microenvironment and Resistance to Treatment Laboratory, INSERM U1194, Montpellier, France
- Institut National de la Santé et de la Recherche Médicale, Montpellier, France
- Institut du Cancer de Montpellier, Montpellier, France
- Université de Montpellier, Montpellier, France
- Cancer Research Institute of Montpellier, Cancer Bioinformatics and Systems Biology Team, INSERM U1194, Montpellier, France
| | - Guillame Belthier
- Institut National de la Santé et de la Recherche Médicale, Montpellier, France
- Université de Montpellier, Montpellier, France
- Institut de Génomique Fonctionnelle, Montpellier, France
- Centre National de la Recherche Scientifique, Montpellier, France
| | - Gilles Doumont
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), rue Adrienne Bolland 8, B-6041 Charleroi (Gosselies), Belgium
| | - Gaetan Van Simaeys
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), rue Adrienne Bolland 8, B-6041 Charleroi (Gosselies), Belgium
- Nuclear Medicine department, ULB Hôpital Érasme, route de Lennik 808, B-1070 Brussels, Belgium
| | - Simon Lacroix
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), rue Adrienne Bolland 8, B-6041 Charleroi (Gosselies), Belgium
- Nuclear Medicine department, ULB Hôpital Érasme, route de Lennik 808, B-1070 Brussels, Belgium
| | - Takehiko Yokobori
- Gunma University Initiative for Advanced Research, International Open Laboratory, Universities of Liege and Montpellier Laboratory, Gunma University, Gunma, Japan
| | - Bilguun Erkhem-Ochir
- Gunma University Initiative for Advanced Research, International Open Laboratory, Universities of Liege and Montpellier Laboratory, Gunma University, Gunma, Japan
| | - Patrick Balaguer
- Institut National de la Santé et de la Recherche Médicale, Montpellier, France
- Institut du Cancer de Montpellier, Montpellier, France
- Université de Montpellier, Montpellier, France
- Cancer Research Institute of Montpellier, Hormone Signaling and Cancer Laboratory, Montpellier, France
| | - Vincent Cavailles
- Institut National de la Santé et de la Recherche Médicale, Montpellier, France
- Institut du Cancer de Montpellier, Montpellier, France
- Université de Montpellier, Montpellier, France
- Cancer Research Institute of Montpellier, Hormone Signaling and Cancer Laboratory, Montpellier, France
| | - Eric Fabbrizio
- Institut National de la Santé et de la Recherche Médicale, Montpellier, France
- Institut du Cancer de Montpellier, Montpellier, France
- Université de Montpellier, Montpellier, France
- Cancer Research Institute of Montpellier, Oncogenic Pathways in Cancer Laboratory, INSERM U1194, Montpellier, France
| | | | | | - Olivier Detry
- Department of Abdominal Surgery, University Hospital, University of Liège, Liège, Belgium
| | - Guy Jerusalem
- Department of Medical Oncology, University Hospital, University of Liège, Liège, Belgium
| | - Serge Goldman
- Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), rue Adrienne Bolland 8, B-6041 Charleroi (Gosselies), Belgium
- Nuclear Medicine department, ULB Hôpital Érasme, route de Lennik 808, B-1070 Brussels, Belgium
| | - Philippe Delvenne
- Department of Pathology, University Hospital, University of Liège, Liège, Belgium
| | - Akeila Bellahcène
- Metastasis Research Laboratory, GIGA Cancer, University of Liège, Liège, Belgium
| | - Julie Pannequin
- Institut National de la Santé et de la Recherche Médicale, Montpellier, France
- Université de Montpellier, Montpellier, France
- Institut de Génomique Fonctionnelle, Montpellier, France
- Centre National de la Recherche Scientifique, Montpellier, France
| | - Vincent Castronovo
- Metastasis Research Laboratory, GIGA Cancer, University of Liège, Liège, Belgium
| | - Andrei Turtoi
- Cancer Research Institute of Montpellier, Tumor Microenvironment and Resistance to Treatment Laboratory, INSERM U1194, Montpellier, France
- Institut National de la Santé et de la Recherche Médicale, Montpellier, France
- Institut du Cancer de Montpellier, Montpellier, France
- Université de Montpellier, Montpellier, France
- Gunma University Initiative for Advanced Research, International Open Laboratory, Universities of Liege and Montpellier Laboratory, Gunma University, Gunma, Japan
| |
Collapse
|
43
|
Puttaert D, Coquelet N, Wens V, Peigneux P, Fery P, Rovai A, Trotta N, Sadeghi N, Coolen T, Bier JC, Goldman S, De Tiège X. Alterations in resting-state network dynamics along the Alzheimer's disease continuum. Sci Rep 2020; 10:21990. [PMID: 33319785 PMCID: PMC7738511 DOI: 10.1038/s41598-020-76201-3] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Accepted: 10/26/2020] [Indexed: 12/26/2022] Open
Abstract
Human brain activity is intrinsically organized into resting-state networks (RSNs) that transiently activate or deactivate at the sub-second timescale. Few neuroimaging studies have addressed how Alzheimer's disease (AD) affects these fast temporal brain dynamics, and how they relate to the cognitive, structural and metabolic abnormalities characterizing AD. We aimed at closing this gap by investigating both brain structure and function using magnetoencephalography (MEG) and hybrid positron emission tomography-magnetic resonance (PET/MR) in 10 healthy elders, 10 patients with subjective cognitive decline (SCD), 10 patients with amnestic mild cognitive impairment (aMCI) and 10 patients with typical Alzheimer's disease with dementia (AD). The fast activation/deactivation state dynamics of RSNs were assessed using hidden Markov modeling (HMM) of power envelope fluctuations at rest measured with MEG. Correlations were sought between temporal properties of HMM states and participants' cognitive test scores, whole hippocampal grey matter volume and regional brain glucose metabolism. The posterior default-mode network (DMN) was less often activated and for shorter durations in AD patients than matched healthy elders. No significant difference was found in patients with SCD or aMCI. The time spent by participants in the activated posterior DMN state did not correlate significantly with cognitive scores, nor with the whole hippocampal volume. However, it correlated positively with the regional glucose consumption in the right dorsolateral prefrontal cortex (DLPFC). AD patients present alterations of posterior DMN power activation dynamics at rest that identify an additional electrophysiological correlate of AD-related synaptic and neural dysfunction. The right DLPFC may play a causal role in the activation of the posterior DMN, possibly linked to the occurrence of mind wandering episodes. As such, these data might suggest a neural correlate of the decrease in mind wandering episodes reported in pathological aging.
Collapse
Affiliation(s)
- D Puttaert
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium. .,Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences (CRCN), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.
| | - N Coquelet
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - V Wens
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - P Peigneux
- Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences (CRCN), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - P Fery
- Neuropsychology and Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences (CRCN), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Service of Neuropsychology and Speech Therapy, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - A Rovai
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - N Trotta
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - N Sadeghi
- Department of Radiology, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - T Coolen
- Department of Radiology, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - J-C Bier
- Department of Neurology, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - S Goldman
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - X De Tiège
- Laboratoire de Cartographie fonctionnelle du Cerveau (LCFC), UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| |
Collapse
|
44
|
Sjøgård M, Wens V, Van Schependom J, Costers L, D'hooghe M, D'haeseleer M, Woolrich M, Goldman S, Nagels G, De Tiège X. Brain dysconnectivity relates to disability and cognitive impairment in multiple sclerosis. Hum Brain Mapp 2020; 42:626-643. [PMID: 33242237 PMCID: PMC7814767 DOI: 10.1002/hbm.25247] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Revised: 09/10/2020] [Accepted: 09/29/2020] [Indexed: 12/27/2022] Open
Abstract
The pathophysiology of cognitive dysfunction in multiple sclerosis (MS) is still unclear. This magnetoencephalography (MEG) study investigates the impact of MS on brain resting-state functional connectivity (rsFC) and its relationship to disability and cognitive impairment. We investigated rsFC based on power envelope correlation within and between different frequency bands, in a large cohort of participants consisting of 99 MS patients and 47 healthy subjects. Correlations were investigated between rsFC and outcomes on disability, disease duration and 7 neuropsychological scores within each group, while stringently correcting for multiple comparisons and possible confounding factors. Specific dysconnections correlating with MS-induced physical disability and disease duration were found within the sensorimotor and language networks, respectively. Global network-level reductions in within- and cross-network rsFC were observed in the default-mode network. Healthy subjects and patients significantly differed in their scores on cognitive fatigue and verbal fluency. Healthy subjects and patients showed different correlation patterns between rsFC and cognitive fatigue or verbal fluency, both of which involved a shift in patients from the posterior default-mode network to the language network. Introducing electrophysiological rsFC in a regression model of verbal fluency and cognitive fatigue in MS patients significantly increased the explained variance compared to a regression limited to structural MRI markers (relative thalamic volume and lesion load). This MEG study demonstrates that MS induces distinct changes in the resting-state functional brain architecture that relate to disability, disease duration and specific cognitive functioning alterations. It highlights the potential value of electrophysiological intrinsic rsFC for monitoring the cognitive impairment in patients with MS.
Collapse
Affiliation(s)
- Martin Sjøgård
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Vincent Wens
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB-Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Jeroen Van Schependom
- Center for Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.,National MS Center, Belgium
| | - Lars Costers
- Center for Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium
| | - Marie D'hooghe
- Center for Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.,National MS Center, Belgium
| | - Miguel D'haeseleer
- Center for Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.,National MS Center, Belgium
| | - Mark Woolrich
- Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK
| | - Serge Goldman
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB-Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Guy Nagels
- Center for Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.,National MS Center, Belgium.,St Edmund Hall, University of Oxford, Oxford, UK
| | - Xavier De Tiège
- Laboratoire de Cartographie fonctionnelle du Cerveau, UNI-ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB-Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| |
Collapse
|
45
|
Mjaess G, Vierasu I, Lacroix S, Aoun F, Goldman S, Roumeguère T, Albisinni S. Is there a role for repeating PSMA PET/CT after a negative scan in biochemical recurrent prostate cancer? Acta Oncol 2020; 59:1397-1400. [PMID: 32649263 DOI: 10.1080/0284186x.2020.1790655] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- Georges Mjaess
- Urology Department, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
- Hôtel Dieu de France, Université Saint Joseph, Beyrouth, Liban
| | - Irina Vierasu
- Nuclear Medicine Department, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Simon Lacroix
- Nuclear Medicine Department, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Fouad Aoun
- Hôtel Dieu de France, Université Saint Joseph, Beyrouth, Liban
- Urology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
| | - Serge Goldman
- Nuclear Medicine Department, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Thierry Roumeguère
- Urology Department, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
- Urology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
| | - Simone Albisinni
- Urology Department, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| |
Collapse
|
46
|
Paternoster L, Soblet J, Aeby A, De Tiège X, Goldman S, Yue WW, Coppens S, Smits G, Vilain C, Deconinck N. Novel homozygous variant of carbonic anhydrase 8 gene expanding the phenotype of cerebellar ataxia, mental retardation, and disequilibrium syndrome subtype 3. Am J Med Genet A 2020; 182:2685-2693. [PMID: 32808436 DOI: 10.1002/ajmg.a.61805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2020] [Revised: 06/23/2020] [Accepted: 06/25/2020] [Indexed: 11/11/2022]
Abstract
We report the case of an 11-year-old Syrian girl born to consanguineous parents, who presents an ataxic gait from early childhood. On clinical examination, she presented a severe static - kinetic cerebellar syndrome, walking without support is possible for short distances only. Strikingly, three consecutive MRIs did not show any sign of cerebellar abnormalities, but a brain positron emission tomography (PET) using [18F]-fluorodeoxyglucose (FDG) demonstrated a clear decrease in glucose metabolism in the cerebellum as well as the anterior and medial temporal lobe bilaterally. A clinical exome analysis identified a novel homozygous c.251A > G (p.Asn84Ser) likely pathogenic variant in the carbonic anhydrase 8 (CA8) gene. CA8 mutations cause cerebellar ataxia, mental retardation, and disequilibrium syndrome subtype 3 (CAMRQ3), a rare genetically autosomal recessive disorder, only described in four families, so far with the frequent observation of quadrupedal gait. The proband differed with other reported CA8 mutations by the absence of clear cerebellar signs on brain MRI and the presence of focal seizures. This report expands the clinical spectrum associated with mutations in CA8 and illustrates the possible discrepancy between (mild) neuro-radiological images (MRI) and (severe) clinical phenotype in young individuals. In contrast, the observation of clear cerebellar abnormal metabolic findings suggests that the FDG-PET scan may be used as an early marker for hereditary ataxia.
Collapse
Affiliation(s)
- Lionel Paternoster
- Faculté de Médecine ULB, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Julie Soblet
- Department of Genetics, Hôpital Universitaire des Enfants Reine Fabiola, ULB Center of Human Genetics, Université Libre de Bruxelles (ULB), Brussels, Belgium.,Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles (ULB), Brussels, Belgium.,Interuniversity Institute of Bioinformatics in Brussels, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Alec Aeby
- Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Xavier De Tiège
- Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium.,Laboratoire de Cartographie fonctionnelle du Cerveau, ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Serge Goldman
- Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium.,Laboratoire de Cartographie fonctionnelle du Cerveau, ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Wyatt W Yue
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Sandra Coppens
- Department of Genetics, Hôpital Universitaire des Enfants Reine Fabiola, ULB Center of Human Genetics, Université Libre de Bruxelles (ULB), Brussels, Belgium.,Neuromuscular Reference Center, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Guillaume Smits
- Department of Genetics, Hôpital Universitaire des Enfants Reine Fabiola, ULB Center of Human Genetics, Université Libre de Bruxelles (ULB), Brussels, Belgium.,Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles (ULB), Brussels, Belgium.,Interuniversity Institute of Bioinformatics in Brussels, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Catheline Vilain
- Department of Genetics, Hôpital Universitaire des Enfants Reine Fabiola, ULB Center of Human Genetics, Université Libre de Bruxelles (ULB), Brussels, Belgium.,Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles (ULB), Brussels, Belgium.,Interuniversity Institute of Bioinformatics in Brussels, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Nicolas Deconinck
- Department of Pediatric Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium.,Neuromuscular Reference Center, Université Libre de Bruxelles (ULB), Brussels, Belgium
| |
Collapse
|
47
|
Coolen T, Lolli V, Sadeghi N, Rovai A, Trotta N, Taccone FS, Creteur J, Henrard S, Goffard JC, Dewitte O, Naeije G, Goldman S, De Tiège X. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology 2020; 95:e2016-e2027. [PMID: 32546654 DOI: 10.1212/wnl.0000000000010116] [Citation(s) in RCA: 171] [Impact Index Per Article: 42.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2020] [Accepted: 06/09/2020] [Indexed: 12/15/2022] Open
Abstract
OBJECTIVES The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered to have potential neuroinvasiveness that might lead to acute brain disorders or contribute to respiratory distress in patients with coronavirus disease 2019 (COVID-19). This study investigates the occurrence of structural brain abnormalities in non-survivors of COVID-19 in a virtopsy framework. METHODS In this prospective, monocentric, case series study, consecutive patients who fulfilled the following inclusion criteria benefited from an early postmortem structural brain MRI: death <24 hours, SARS-CoV-2 detection on nasopharyngeal swab specimen, chest CT scan suggestive of COVID-19, absence of known focal brain lesion, and MRI compatibility. RESULTS Among the 62 patients who died of COVID-19 from March 31, 2020, to April 24, 2020, at our institution, 19 decedents fulfilled the inclusion criteria. Parenchymal brain abnormalities were observed in 4 decedents: subcortical microbleeds and macrobleeds (2 decedents), cortico-subcortical edematous changes evocative of posterior reversible encephalopathy syndrome (PRES; 1 decedent), and nonspecific deep white matter changes (1 decedent). Asymmetric olfactory bulbs were found in 4 other decedents without downstream olfactory tract abnormalities. No brainstem MRI signal abnormality was observed. CONCLUSIONS Postmortem brain MRI demonstrates hemorrhagic and PRES-related brain lesions in non-survivors of COVID-19. SARS-CoV-2-related olfactory impairment seems to be limited to olfactory bulbs. Brainstem MRI findings do not support a brain-related contribution to respiratory distress in COVID-19.
Collapse
Affiliation(s)
- Tim Coolen
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Valentina Lolli
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Niloufar Sadeghi
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Antonin Rovai
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Nicola Trotta
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Fabio Silvio Taccone
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Jacques Creteur
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Sophie Henrard
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Jean-Christophe Goffard
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Olivier Dewitte
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Gilles Naeije
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Serge Goldman
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium
| | - Xavier De Tiège
- From the Department of Radiology (T.C., V.L., N.S.), Department of Nuclear Medicine (A.R., N.T., S.G., X.D.T.), Intensive Care Unit (F.S.T., J.C.), Department of Internal Medicine (S.H., J.-C.G.), Department of Neurosurgery (O.D.W.), and Department of Neurology (G.N.), CUB Hôpital Erasme, and Laboratoire de Cartographie fonctionnelle du Cerveau (T.C., V.L., A.R., N.T., S.G., X.D.T.), UNI-ULB Neuroscience Institute, Université libre de Bruxelles, Brussels, Belgium.
| |
Collapse
|
48
|
Coolen T, Wens V, Vander Ghinst M, Mary A, Bourguignon M, Naeije G, Peigneux P, Sadeghi N, Goldman S, De Tiège X. Frequency-Dependent Intrinsic Electrophysiological Functional Architecture of the Human Verbal Language Network. Front Integr Neurosci 2020; 14:27. [PMID: 32528258 PMCID: PMC7264165 DOI: 10.3389/fnint.2020.00027] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2020] [Accepted: 04/16/2020] [Indexed: 11/13/2022] Open
Abstract
Functional magnetic resonance imaging (fMRI) allowed the spatial characterization of the resting-state verbal language network (vLN). While other resting-state networks (RSNs) were matched with their electrophysiological equivalents at rest and could be spectrally defined, such correspondence is lacking for the vLN. This magnetoencephalography (MEG) study aimed at defining the spatio-spectral characteristics of the neuromagnetic intrinsic functional architecture of the vLN. Neuromagnetic activity was recorded at rest in 100 right-handed healthy adults (age range: 18-41 years). Band-limited power envelope correlations were performed within and across frequency bands (θ, α, β, and low γ) from a seed region placed in the left Broca's area, using static orthogonalization as leakage correction. K-means clustering was used to segregate spatio-spectral clusters of resting-state functional connectivity (rsFC). Remarkably, unlike other RSNs, within-frequency long-range rsFC from the left Broca's area was not driven by one main carrying frequency but was characterized by a specific spatio-spectral pattern segregated along the ventral (predominantly θ and α) and dorsal (β and low-γ bands) vLN streams. In contrast, spatial patterns of cross-frequency vLN functional integration were spectrally more widespread and involved multiple frequency bands. Moreover, the static intrinsic functional architecture of the neuromagnetic human vLN involved clearly left-hemisphere-dominant vLN interactions as well as cross-network interactions with the executive control network and postero-medial nodes of the DMN. Overall, this study highlighted the involvement of multiple modes of within and cross-frequency power envelope couplings at the basis of long-range electrophysiological vLN functional integration. As such, it lays the foundation for future works aimed at understanding the pathophysiology of language-related disorders.
Collapse
Affiliation(s)
- Tim Coolen
- Laboratoire de Cartographie fonctionnelle du Cerveau, ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium.,Department of Radiology, CUB-Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Vincent Wens
- Laboratoire de Cartographie fonctionnelle du Cerveau, ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium.,Magnetoencenphalography Unit, Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB-Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Marc Vander Ghinst
- Laboratoire de Cartographie fonctionnelle du Cerveau, ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Alison Mary
- Neuropsychology & Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences, ULB-Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Mathieu Bourguignon
- Laboratoire de Cartographie fonctionnelle du Cerveau, ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium.,BCBL-Basque Center on Cognition, Brain and Language, San Sebastian, Spain.,Laboratoire Cognition Langage et Développement, ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Gilles Naeije
- Laboratoire de Cartographie fonctionnelle du Cerveau, ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Philippe Peigneux
- Neuropsychology & Functional Neuroimaging Research Unit (UR2NF), Center for Research in Cognition and Neurosciences, ULB-Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Niloufar Sadeghi
- Department of Radiology, CUB-Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Serge Goldman
- Laboratoire de Cartographie fonctionnelle du Cerveau, ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium.,Magnetoencenphalography Unit, Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB-Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| | - Xavier De Tiège
- Laboratoire de Cartographie fonctionnelle du Cerveau, ULB Neuroscience Institute (UNI), Université libre de Bruxelles (ULB), Brussels, Belgium.,Magnetoencenphalography Unit, Department of Functional Neuroimaging, Service of Nuclear Medicine, CUB-Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
| |
Collapse
|
49
|
Coquelet N, De Tiège X, Destoky F, Roshchupkina L, Bourguignon M, Goldman S, Peigneux P, Wens V. Comparing MEG and high-density EEG for intrinsic functional connectivity mapping. Neuroimage 2020; 210:116556. [DOI: 10.1016/j.neuroimage.2020.116556] [Citation(s) in RCA: 47] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2019] [Revised: 12/11/2019] [Accepted: 01/14/2020] [Indexed: 01/22/2023] Open
|
50
|
Costers L, Van Schependom J, Laton J, Baijot J, Sjøgård M, Wens V, De Tiège X, Goldman S, D'Haeseleer M, D'hooghe MB, Woolrich M, Nagels G. Spatiotemporal and spectral dynamics of multi-item working memory as revealed by the n-back task using MEG. Hum Brain Mapp 2020; 41:2431-2446. [PMID: 32180307 PMCID: PMC7267970 DOI: 10.1002/hbm.24955] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Revised: 01/21/2020] [Accepted: 02/10/2020] [Indexed: 01/08/2023] Open
Abstract
Multi‐item working memory (WM) is a complex cognitive function thought to arise from specific frequency band oscillations and their interactions. While some theories and consistent findings have been established, there is still a lot of unclarity about the sources, temporal dynamics, and roles of event‐related fields (ERFs) and theta, alpha, and beta oscillations during WM activity. In this study, we performed an extensive whole‐brain ERF and time‐frequency analysis on n‐back magnetoencephalography data from 38 healthy controls. We identified the previously unknown sources of the n‐back M300, the right inferior temporal and parahippocampal gyrus and left inferior temporal gyrus, and frontal theta power increase, the orbitofrontal cortex. We shed new light on the role of the precuneus during n‐back activity, based on an early ERF and theta power increase, and suggest it to be a crucial link between lower‐level and higher‐level information processing. In addition, we provide strong evidence for the central role of the hippocampus in multi‐item WM behavior through the dynamics of theta and alpha oscillatory changes. Almost simultaneous alpha power decreases observed in the hippocampus and occipital fusiform gyri, regions known to be involved in letter processing, suggest that these regions together enable letter recognition, encoding and storage in WM. In summary, this study offers an extensive investigation into the spatial, temporal, and spectral characteristics of n‐back multi‐item WM activity.
Collapse
Affiliation(s)
- Lars Costers
- Center For Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium
| | - Jeroen Van Schependom
- Center For Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.,Departement of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Brussels, Belgium.,Radiology, Universitair Ziekenhuis Brussel, Brussels, Belgium
| | - Jorne Laton
- Center For Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.,Institute of Biomedical Engineering (IBME), University of Oxford, Oxford, UK
| | - Johan Baijot
- Center For Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium
| | - Martin Sjøgård
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), Université Libre de Bruxelles, Brussels, Belgium
| | - Vincent Wens
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), Université Libre de Bruxelles, Brussels, Belgium.,Magnetoencephalography Unit, CUB-Hôpital Erasme, Brussels, Belgium
| | - Xavier De Tiège
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), Université Libre de Bruxelles, Brussels, Belgium.,Magnetoencephalography Unit, CUB-Hôpital Erasme, Brussels, Belgium
| | - Serge Goldman
- Laboratoire de Cartographie Fonctionnelle du Cerveau (LCFC), Université Libre de Bruxelles, Brussels, Belgium.,Magnetoencephalography Unit, CUB-Hôpital Erasme, Brussels, Belgium
| | - Miguel D'Haeseleer
- Center For Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.,Neurology, National MS Center Melsbroek, Melsbroek, Belgium
| | - Marie Beatrice D'hooghe
- Center For Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.,Neurology, National MS Center Melsbroek, Melsbroek, Belgium
| | - Mark Woolrich
- Oxford Centre for Human Brain Activity (OHBA), University of Oxford, Oxford, UK.,Oxford University Centre for Functional MRI of the Brain (FMRIB), University of Oxford, Oxford, UK
| | - Guy Nagels
- Center For Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.,St Edmund Hall, University of Oxford, Oxford, UK.,Neurology, Universitair Ziekenhuis Brussel, Brussels, Belgium
| |
Collapse
|